The American Journal of Cardiology
-
Publication Venue For
-
Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry)..
123:1628-1636.
2019
-
Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial)..
123:1660-1666.
2019
-
Pursuit of the Optimal Antithrombotic Regimen for Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Who Undergo Subsequent Percutaneous Coronary Intervention..
123:1736.
2019
-
Relationship Between Optimism and Outcomes in Patients With Chronic Angina Pectoris..
123:1399-1405.
2019
-
Association of Clinician Knowledge and Statin Beliefs With Statin Therapy Use and Lipid Levels (A Survey of US Practice in the PALM Registry)..
123:1011-1018.
2019
-
Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT)..
123:1193-1201.
2019
-
Relation of Admission Blood Pressure to In-hospital and 90-Day Outcomes in Patients Presenting With Transient Ischemic Attack..
123:1083-1095.
2019
-
Size of Anterior Wall Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention in United States Versus Europe/Australia Versus India (from the CRISP-AMI Randomized Controlled Trial)..
123:1026-1034.
2019
-
Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes..
123:709-716.
2019
-
Predictors and Changes in Cardiac Hemodynamics and Geometry With Transcatheter Aortic Valve Implantation..
123:813-819.
2019
-
Comparison of Outcomes and Frequency of Graft Failure With Use of Free Versus In Situ Internal Mammary Artery Bypass Conduits (from the PREVENT IV Trial)..
123:571-575.
2019
-
Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis)..
123:355-360.
2019
-
Glycated Hemoglobin and Outcomes of Heart Failure (from Get With the Guidelines-Heart Failure)..
123:618-626.
2019
-
Meta-Analysis of Effects of Digoxin on Survival in Patients with Atrial Fibrillation or Heart Failure: An Update..
123:69-74.
2019
-
Relation of Length of Stay to Unplanned Readmissions for Patients Who Undergo Elective Percutaneous Coronary Intervention..
123:33-43.
2019
-
Usefulness of Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Myocardial Infarction..
123:12-18.
2019
-
Usefulness of a Positive Psychology-Motivational Interviewing Intervention to Promote Positive Affect and Physical Activity After an Acute Coronary Syndrome
2019
-
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry)..
122:1638-1646.
2018
-
Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry)..
122:1677-1683.
2018
-
Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status..
122:1451-1458.
2018
-
Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF)..
122:1506-1512.
2018
-
Frequency of Ventricular Arrhythmias and Other Rhythm Abnormalities in Children and Young Adults With the Marfan Syndrome..
122:1429-1436.
2018
-
Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial)..
122:1322-1329.
2018
-
Clinical and Echocardiographic Predictors of Outcomes in Patients With Pulmonary Hypertension..
122:872-878.
2018
-
Effects of a 12-Week mHealth Program on FunctionalCapacity and Physical Activity in Patients With PeripheralArtery Disease..
122:879-884.
2018
-
Renal Function and Exercise Training in AmbulatoryHeart Failure Patients With a Reduced Ejection Fraction..
122:999-1007.
2018
-
Effect of Patent Foramen Ovale in Patients With Pulmonary Hypertension..
122:505-510.
2018
-
Post-Traumatic Stress Disorder and Heart Failure in Men Within the Veteran Affairs Health System..
122:275-278.
2018
-
Relation Between Age and Unplanned Readmissions After Percutaneous Coronary Intervention (Findings from the Nationwide Readmission Database)..
122:220-228.
2018
-
Relation of Early Repolarization (J Point Elevation) to Mortality in Blacks (from the Jackson Heart Study)..
122:340-346.
2018
-
Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)..
122:255-260.
2018
-
Usefulness and Cost-Effectiveness of Universal Echocardiographic Contrast to Detect Left Ventricular Thrombus in Patients with Heart Failure and Reduced Ejection Fraction..
122:121-128.
2018
-
Impact of Balloon Predilatation on Hemodynamics and Outcomes After Transcatheter Aortic Valve Implantation With the Self-Expanding CoreValve Prosthesis..
121:1358-1364.
2018
-
Sedentary Behavior and the Risk of Depression in Patients With Acute Coronary Syndromes..
121:1456-1460.
2018
-
Alcohol Consumption and Risk of Coronary Artery Disease (from the Million Veteran Program).
121:1162-1168.
2018
-
Controversies and Challenges of Ventricular Assist Device Therapy..
121:1219-1224.
2018
-
Influence of Aortic Stiffness on Aortic-Root Growth Rate and Outcome in Patients With the Marfan Syndrome..
121:1094-1101.
2018
-
Relation of Age and Health-Related Quality of Life to Invasive Versus Ischemia-Guided Management of Patients with Non-ST Elevation Myocardial Infarction..
121:789-795.
2018
-
Comparison of Outcomes and Costs Associated With Aspirin ± Clopidogrel After Coronary Artery Bypass Grafting..
121:709-714.
2018
-
Comparison of Incidence of Left Ventricular Systolic Dysfunction Among Patients With Left Bundle Branch Block Versus Those With Normal QRS Duration..
120:1990-1997.
2017
-
Effect of Age and Renal Function on Survival After Left Ventricular Assist Device Implantation..
120:2221-2225.
2017
-
Evaluation of Industrial Compensation to Cardiologists in 2015..
120:2294-2298.
2017
-
Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)..
120:1837-1840.
2017
-
Usefulness of Coronary Artery Calcium to Predict Heart Failure With Preserved Ejection Fraction in Men Versus Women (from the Multi-Ethnic Study of Atherosclerosis)..
120:1847-1853.
2017
-
Usefulness of Myocardial Annular Velocity Change During Mental Stress to Predict Cardiovascular Outcome in Patients With Coronary Artery Disease (From the Responses of Mental Stress-Induced Myocardial Ischemia to Escitalopram Treatment Trial)..
120:1495-1500.
2017
-
Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation..
120:1820-1829.
2017
-
Biomarkers in Pulmonary Vascular Disease: Gauging Response to Therapy..
120:S89-S95.
2017
-
Impact of Tachyarrhythmia Detection Rate and Time from Detection to Shock on Outcomes in Nationwide US Practice..
120:1325-1331.
2017
-
Meta-analysis of Placebo-Controlled Randomized Controlled Trials on the Prevalence of Statin Intolerance..
120:774-781.
2017
-
Serial Heart Rates, Guideline-Directed Beta Blocker Use, and Outcomes in Patients With Chronic Heart Failure With Reduced Ejection Fraction..
120:803-808.
2017
-
Usefulness of Pulse Amplitude Changes During the Valsalva Maneuver Measured Using Finger Photoplethysmography to Identify Elevated Pulmonary Capillary Wedge Pressure in Patients With Heart Failure..
120:966-972.
2017
-
Right-Sided Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction and Worsening Renal Function..
120:274-278.
2017
-
Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network)..
120:98-105.
2017
-
Usefulness of Multiple Biomarkers for Predicting Incident Major Adverse Cardiac Events in Patients Who Underwent Diagnostic Coronary Angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study)..
120:25-32.
2017
-
Comparison of Clinical Characteristics and Outcomes of Patients With Versus Without Diabetes Mellitus and With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease)..
119:1703-1709.
2017
-
Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF])..
119:1763-1769.
2017
-
Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF)..
119:2003-2009.
2017
-
Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease..
119:1942-1948.
2017
-
Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials)..
119:1710-1716.
2017
-
Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Trial)..
119:1989-1996.
2017
-
Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease..
119:1344-1351.
2017
-
Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II])..
119:1590-1595.
2017
-
Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia..
119:1401-1406.
2017
-
Comparison of Delay Times from Symptom Onset to Medical Contact in Blacks Versus Whites With Acute Myocardial Infarction..
119:1127-1134.
2017
-
Incidence and Predictors of Left Atrial Appendage Thrombus in Patients Treated With Nonvitamin K Oral Anticoagulants Versus Warfarin Before Catheter Ablation for Atrial Fibrillation..
119:1017-1022.
2017
-
Usefulness of a Noninvasive Device to Identify Elevated Left Ventricular Filling Pressure Using Finger Photoplethysmography During a Valsalva Maneuver..
119:1053-1060.
2017
-
Comparative Outcomes of Surgical and Transcatheter Aortic Valve Replacement for Aortic Stenosis in Nonagenarians..
119:893-899.
2017
-
Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus..
119:753-759.
2017
-
Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock..
119:845-851.
2017
-
Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function..
119:886-892.
2017
-
Body Weights in Adults With Congenital Heart Disease and the Obesity Frequency.
119:638-642.
2017
-
Implications of the LEGACY trial on US Atrial Fibrillation Patients: An NCDR Research to Practice (R2P) Project..
119:579-584.
2017
-
Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials)..
119:397-403.
2017
-
Implications of Serum Chloride Homeostasis in Acute Heart Failure (from ROSE-AHF)..
119:78-83.
2017
-
Serum Potassium Levels and Outcome in Acute Heart Failure (Data from the PROTECT and COACH Trials)..
119:290-296.
2017
-
Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus..
118:1941-1947.
2016
-
Gender Differences in Associations Between Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention and Adverse Outcomes..
118:1661-1668.
2016
-
Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease..
118:1655-1660.
2016
-
Anticoagulation After Heart Valve Replacement or Transcatheter Valve Implantation..
118:1419-1426.
2016
-
Effect of Release of the First Pediatric Appropriate Use Criteria on Transthoracic Echocardiogram Ordering Practice..
118:1545-1551.
2016
-
Meta-Analysis Comparing Complete Revascularization Versus Infarct-Related Only Strategies for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease..
118:1466-1472.
2016
-
Relation of Angina Pectoris to Outcomes, Quality of Life, and Response to Exercise Training in Patients With Chronic Heart Failure (from HF-ACTION)..
118:1211-1216.
2016
-
Trends in Bare-Metal Stent Use in the United States in Patients Aged ≥65 Years (from the CathPCI Registry)..
118:959-966.
2016
-
Electrocardiographic J Wave and Cardiovascular Outcomes in the General Population (from the Atherosclerosis Risk In Communities Study)..
118:811-815.
2016
-
Oxidized Low-Density Lipoprotein-β2-Glycoprotein I Complex But Not Free Oxidized LDL Is Associated With the Presence and Severity of Coronary Artery Disease..
118:673-678.
2016
-
Usefulness of Palliative Care to Complement the Management of Patients on Left Ventricular Assist Devices..
118:733-738.
2016
-
Comparison of Long-Term Mortality of Patients Aged ≤40 Versus >40 Years With Acute Myocardial Infarction..
118:319-325.
2016
-
Frequency of Disparities in Laboratory Testing After Statin Initiation in Subjects ≥65 Years..
118:376-382.
2016
-
Effect of a Multidisciplinary Approach for the Management of Patients With Atrial Fibrillation in the Emergency Department on Hospital Admission Rate and Length of Stay..
118:64-71.
2016
-
Relation of Baseline Renal Dysfunction With Outcomes in Patients Undergoing Popliteal and Infrapopliteal Percutaneous Peripheral Arterial Interventions..
118:298-302.
2016
-
Comparison of Frequency of Frailty and Severely Impaired Physical Function in Patients ≥60 Years Hospitalized With Acute Decompensated Heart Failure Versus Chronic Stable Heart Failure With Reduced and Preserved Left Ventricular Ejection Fraction..
117:1953-1958.
2016
-
Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial)..
117:1771-1778.
2016
-
Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study..
117:1877-1883.
2016
-
Should Physicians be Encouraged to use Generic Names and to Prescribe Generic Drugs?.
117:1851-1852.
2016
-
Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial)..
117:1127-1134.
2016
-
Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention..
117:1256-1266.
2016
-
Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure..
117:1144-1150.
2016
-
Conflicts of Interest and Outcomes of Cardiovascular Trials..
117:858-860.
2016
-
Relation of Activated Clotting Times During Percutaneous Coronary Intervention to Outcomes..
117:703-708.
2016
-
Relation of Elevated Heart Rate in Patients With Heart Failure With Reduced Ejection Fraction to One-Year Outcomes and Costs..
117:946-951.
2016
-
Effects of Polyunsaturated Fatty Acid Treatment on Postdischarge Outcomes After Acute Myocardial Infarction..
117:340-346.
2016
-
Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial)..
117:611-616.
2016
-
Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial)..
117:404-411.
2016
-
Usefulness of Intra-aortic Balloon Pump Counterpulsation..
117:469-476.
2016
-
Usefulness of Von Willebrand Factor Activity Indexes to Predict Therapeutic Response in Hypertrophic Cardiomyopathy..
117:436-442.
2016
-
Impact of Funding Source on Clinical Trial Results Including Cardiovascular Outcome Trials..
116:1944-1947.
2015
-
Outcomes and worsening renal function in patients hospitalized with heart failure with preserved ejection fraction..
116:1534-1540.
2015
-
Associations Between Day of Admission and Day of Surgery on Outcome and Resource Utilization in Infants With Hypoplastic Left Heart Syndrome Who Underwent Stage I Palliation (from the Single Ventricle Reconstruction Trial)..
116:1263-1269.
2015
-
Effect of Falls on Frequency of Atrial Fibrillation and Mortality Risk (from the REasons for Geographic And Racial Differences in Stroke Study)..
116:1213-1218.
2015
-
Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical Trials..
116:1304-1310.
2015
-
Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous Flow..
116:573-579.
2015
-
Contemporary cardiovascular device clinical trials (trends and patterns 2001 to 2012)..
116:307-312.
2015
-
Frequency and Effects of Excess Dosing of Anticoagulants in Patients ≤55 Years With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention (from the VIRGO Study)..
116:1-7.
2015
-
Comparison of aortic annulus size by transesophageal echocardiography and computed tomography angiography with direct surgical measurement..
115:1568-1573.
2015
-
Evaluation of Cardiac Magnetic Resonance as a Surrogate in ST-Segment Elevation Myocardial Infarction..
115:1607-1614.
2015
-
State mandated public reporting and outcomes of percutaneous coronary intervention in the United States..
115:1494-1501.
2015
-
Statin Treatment by Low-Density Lipoprotein Cholesterol Levels in Patients With Non-ST-Segment Elevation Myocardial Infarction/Unstable Angina Pectoris (from the CRUSADE Registry)..
115:1655-1660.
2015
-
Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial)..
115:1325-1332.
2015
-
Impact of exercise stress testing on diagnostic gene expression in patients with obstructive and nonobstructive coronary artery disease..
115:1346-1350.
2015
-
Outcomes after nonemergent electrical cardioversion for atrial arrhythmias..
115:1407-1414.
2015
-
Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial)..
115:1265-1272.
2015
-
Relation of fish oil supplementation to markers of atherothrombotic risk in patients with cardiovascular disease not receiving lipid-lowering therapy..
115:1204-1211.
2015
-
Effect of minor liver function test abnormalities and values within the normal range on survival in heart failure..
115:938-941.
2015
-
Exercise heart rates in patients with hypertrophic cardiomyopathy..
115:1144-1150.
2015
-
Long-term prognosis and risk heterogeneity of heart failure complicating acute myocardial infarction..
115:872-878.
2015
-
ST2 and prognosis in acutely decompensated heart failure: the International ST2 Consensus Panel..
115:26B-31B.
2015
-
ST2 in Pulmonary Disease..
115:44B-47B.
2015
-
ST2 testing for chronic heart failure therapy monitoring: the International ST2 Consensus Panel..
115:70B-75B.
2015
-
The International ST2 Consensus Panel: Introduction..
115:1B-2B.
2015
-
The biology of ST2: the International ST2 Consensus Panel..
115:3B-7B.
2015
-
Meta-analysis of direct and indirect comparison of ticagrelor and prasugrel effects on platelet reactivity..
115:716-723.
2015
-
Usefulness of retinal microvascular endothelial dysfunction as a predictor of coronary artery disease..
115:609-613.
2015
-
Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease.
115:316-322.
2015
-
Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease..
115:316-322.
2015
-
Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarction..
115:428-433.
2015
-
Outcomes of patients with acute decompensated heart failure managed by cardiologists versus noncardiologists..
115:466-471.
2015
-
Glycoprotein IIb/IIIa receptor inhibitors in combination with vorapaxar, a platelet thrombin receptor antagonist, among patients with non-ST-segment elevation acute coronary syndromes (from the TRACER trial).
115:1325-1332.
2015
-
Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the strategic reperfusion early after myocardial infarction [STREAM] study).
114:811-819.
2015
-
Predictors and progression of aortic stenosis in patients with preserved left ventricular ejection fraction..
115:86-92.
2015
-
Relation of dyspnea severity on admission for acute heart failure with outcomes and costs.
115:75-81.
2015
-
Relation of dyspnea severity on admission for acute heart failure with outcomes and costs..
115:75-81.
2015
-
Statin Treatment by Low-Density Lipoprotein Cholesterol Levels in Patients With Non-ST-Segment Elevation Myocardial Infarction/Unstable Angina Pectoris (from the CRUSADE Registry).
115:1655-1660.
2015
-
From acute decompensated to chronic heart failure..
114:1923-1929.
2014
-
Prognostic value of angiographic lesion complexity in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the acute catheterization and urgent intervention triage strategy trial)..
114:1638-1645.
2014
-
Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial)..
114:1713-1721.
2014
-
Persistence of evidence-based medication use after discharge from academic versus nonacademic hospitals among patients with non-ST-segment elevation myocardial infarction..
114:1479-1484.
2014
-
Prognostic usefulness of insulin-like growth factor-binding protein 7 in heart failure with reduced ejection fraction: a novel biomarker of myocardial diastolic function?.
114:1543-1549.
2014
-
Impact of diabetes mellitus on clinical characteristics, management, and in-hospital outcomes in patients with acute myocardial infarction (from the NCDR).
114:1136-1144.
2014
-
Characteristics and outcomes of patients with heart failure and discordant findings by right-sided heart catheterization and cardiopulmonary exercise testing..
114:1059-1064.
2014
-
Impact of diabetes mellitus on clinical characteristics, management, and in-hospital outcomes in patients with acute myocardial infarction (from the NCDR)..
114:1136-1144.
2014
-
Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease..
114:716-722.
2014
-
Comparison of the use of hemodynamic support in patients ≥80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the multicenter protect II randomized study).
114:657-664.
2014
-
Comparison of the use of hemodynamic support in patients ≥80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study)..
114:657-664.
2014
-
Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial)..
114:743-750.
2014
-
Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study)..
114:811-819.
2014
-
Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial)..
114:665-673.
2014
-
Impact of statin use on exercise-induced cardiac troponin elevations..
114:624-628.
2014
-
Comparison of hybrid coronary revascularization versus coronary artery bypass grafting in patients≥65 years with multivessel coronary artery disease..
114:224-229.
2014
-
Comparison of long-term postoperative sequelae in patients with tetralogy of Fallot versus isolated pulmonic stenosis..
114:300-304.
2014
-
Cost analysis of periprocedural imaging in patients undergoing catheter ablation for atrial fibrillation..
114:266-271.
2014
-
Frequency of nonsystem delays in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention and implications for door-to-balloon time reporting (from the American Heart Association Mission: Lifeline program)..
114:24-28.
2014
-
Analysis of geographic variations in the diagnosis and treatment of patients with aortic stenosis in North Carolina..
113:1874-1878.
2014
-
Comparison of the relation between left ventricular anatomy and QRS duration in patients with cardiomyopathy with versus without left bundle branch block..
113:1717-1722.
2014
-
Angiographic outcomes with early eptifibatide therapy in non-ST-segment elevation acute coronary syndrome (from the EARLY ACS trial).
113:1297-1305.
2014
-
Angiographic outcomes with early eptifibatide therapy in non-ST-segment elevation acute coronary syndrome (from the EARLY ACS Trial)..
113:1297-1305.
2014
-
Characteristics and outcomes in patients undergoing percutaneous coronary intervention following cardiac arrest (from the NCDR)..
113:1087-1092.
2014
-
Association of aspirin dose and vorapaxar safety and efficacy in patients with non-st-segment elevation acute coronary syndrome (from the tracer trial).
113:936-944.
2014
-
Characteristics, management, and outcomes of cocaine-positive patients with acute coronary syndrome (from the National Cardiovascular Data Registry).
113:749-756.
2014
-
Characteristics, management, and outcomes of cocaine-positive patients with acute coronary syndrome (from the National Cardiovascular Data Registry)..
113:749-756.
2014
-
Predictors of reperfusion delay in patients with ST elevation myocardial infarction self-transported to the hospital (from the American Heart Association's Mission: Lifeline Program).
113:798-802.
2014
-
Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study)..
113:504-510.
2014
-
Impact of hemodynamic support with impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial).
113:222-228.
2014
-
Influence of presenting electrocardiographic findings on the treatment and outcomes of patients with non-ST-segment elevation myocardial infarction.
113:256-261.
2014
-
Characteristics and outcomes in patients undergoing percutaneous coronary intervention following cardiac arrest (from the NCDR).
113:1087-1092.
2014
-
Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction.
113:117-122.
2014
-
Long-Term Prognosis and Risk Heterogeneity of Heart Failure Complicating Acute Myocardial Infarction
2014
-
Longitudinal follow-up of implantable cardioverter defibrillator leads..
113:103-106.
2014
-
Mechanisms of functional mitral regurgitation in ischemic cardiomyopathy determined by transesophageal echocardiography (from the surgical treatment for ischemic heart failure trial).
112:1812.
2013
-
Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial)..
112:1763-1769.
2013
-
Impact of Aortic Valve Replacement for Aortic Stenosis on Dynamic Mitral Annular Motion and Geometry.
112:1445-1449.
2013
-
New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry)..
112:1390-1395.
2013
-
Comparative effectiveness of pharmacotherapies for prevention of atrial fibrillation following coronary artery bypass surgery..
112:954-960.
2013
-
Importance of total ischemic time and preprocedural infarct-related artery blood flow in predicting infarct size in patients with anterior wall myocardial infarction (from the CRISP-AMI Trial)..
112:911-917.
2013
-
A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk..
112:231-237.
2013
-
Reply: To PMID 23245838..
111:1079.
2013
-
Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF)..
111:582-587.
2013
-
Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study)..
111:374-381.
2013
-
Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial)..
111:574-581.
2013
-
Temporal trends in medical therapies for ST- and non-ST elevation myocardial infarction: (from the Atherosclerosis Risk in Communities [ARIC] Surveillance Study)..
111:305-311.
2013
-
A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.
112:231-237.
2013
-
Association between bilirubin and mode of death in severe systolic heart failure.
111:1192-1197.
2013
-
Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
111:582-587.
2013
-
Characteristics and In-Hospital Outcomes of Patients With Non-ST-Segment Elevation Myocardial Infarction Undergoing an Invasive Strategy According to Hemoglobin Levels
2013
-
Characteristics and in-hospital outcomes of patients with non-st-segment elevation myocardial infarction undergoing an invasive strategy according to hemoglobin levels.
111:1099-1103.
2013
-
Comparative effectiveness of pharmacotherapies for prevention of atrial fibrillation following coronary artery bypass surgery.
112:954-960.
2013
-
Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics..
111:79-84.
2013
-
Emergency room and inpatient use after cardiac pacemaker implantation.
111:563-568.
2013
-
Hemoglobin, exercise training, and health status in patients with chronic heart failure (from the HF-ACTION randomized controlled trial).
112:971-976.
2013
-
Impact of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump on Prognostically Important Clinical Outcomes in Patients Undergoing High-Risk Percutaneous Coronary Intervention (from the PROTECT II Randomized Trial)
2013
-
Importance of total ischemic time and preprocedural infarct-related artery blood flow in predicting infarct size in patients with anterior wall myocardial infarction (from the CRISP-AMI trial).
112:911-917.
2013
-
Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction.
111:178-184.
2013
-
Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction..
111:178-184.
2013
-
Influence of Presenting Electrocardiographic Findings on the Treatment and Outcomes of Patients With Non-ST-Segment Elevation Myocardial Infarction
2013
-
Mechanisms of Functional Mitral Regurgitation in Ischemic Cardiomyopathy Determined by Transesophageal Echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial)
2013
-
Preoperative anxiety as a predictor of mortality and major morbidity in patients aged >70 years undergoing cardiac surgery..
111:137-142.
2013
-
Relation of Admission High-Density Lipoprotein Cholesterol Level and In-Hospital Mortality in Patients With Acute Non-ST Segment Elevation Myocardial Infarction (from the National Cardiovascular Data Registry)
2013
-
Relation of admission high-density lipoprotein cholesterol level and in-hospital mortality in patients with acute non-st segment elevation myocardial infarction (from the National Cardiovascular Data Registry).
112:1057-1062.
2013
-
Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation..
111:219-224.
2013
-
Capecitabine-induced chest pain relieved by diltiazem..
110:1623-1626.
2012
-
Gender does not affect postdischarge outcomes in patients hospitalized for worsening heart failure with reduced ejection fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan [EVEREST] Trial)..
110:1803-1808.
2012
-
Prognostic value of monocyte count in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial)..
110:1657-1662.
2012
-
Relative prognostic value of baseline Q wave and time from symptom onset among men and women with ST-elevation myocardial infarction undergoing percutaneous coronary intervention..
110:1555-1560.
2012
-
Atherosclerotic risk factors and their association with hospital mortality among patients with first myocardial infarction (from the National Registry of Myocardial Infarction)..
110:1256-1261.
2012
-
Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes..
110:1240-1248.
2012
-
Effect of obesity on B-type natriuretic peptide levels in patients with pulmonary arterial hypertension..
110:909-914.
2012
-
Comparative value of coronary artery calcium and multiple blood biomarkers for prognostication of cardiovascular events..
109:1449-1453.
2012
-
Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients..
109:1266-1271.
2012
-
Comparison of bleeding and in-hospital mortality in Asian-Americans versus Caucasian-Americans with ST-elevation myocardial infarction receiving reperfusion therapy..
109:925-931.
2012
-
Impact of anemia on platelet response to clopidogrel in patients undergoing percutaneous coronary stenting..
109:1148-1153.
2012
-
Predicting costs among medicare beneficiaries with heart failure..
109:705-711.
2012
-
Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis..
109:320-326.
2012
-
Cardiologist concordance with the American College of Cardiology Appropriate Use Criteria for cardiac testing in patients with coronary artery disease.
110:337-344.
2012
-
Comparison of clinical characteristics, treatments and outcomes of patients with ST-elevation acute myocardial infarction with versus without new or presumed new left bundle branch block (from NCDR ®
).
109:497-501.
2012
-
Downstream testing and subsequent procedures after coronary computed tomographic angiography following coronary stenting in patients ≥65 years of age.
110:776-783.
2012
-
Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry).
110:350-355.
2012
-
Meta-analysis comparing Bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary intervention.
110:599-606.
2012
-
Red blood cell indices and development of hospital-acquired anemia during acute myocardial infarction.
109:1104-1110.
2012
-
Type-selective benefits of medications in treatment of acute aortic dissection (from the International Registry of Acute Aortic Dissection [IRAD])..
109:122-127.
2012
-
Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease..
108:1552-1555.
2011
-
Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy)..
108:1542-1546.
2011
-
Associations of patient demographic characteristics and regional physician density with early physician follow-up among medicare beneficiaries hospitalized with heart failure..
108:985-991.
2011
-
Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals..
108:979-984.
2011
-
Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise - STRRIDE-AT/RT)..
108:838-844.
2011
-
Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry)..
107:1751-1756.
2011
-
Early detection and prediction of cardiotoxicity in chemotherapy-treated patients..
107:1375-1380.
2011
-
Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry)..
107:1441-1446.
2011
-
In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™..
107:1136-1143.
2011
-
Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention..
107:871-878.
2011
-
Ascending thoracic aorta dimension and outcomes in acute type B dissection (from the International Registry of Acute Aortic Dissection [IRAD])..
107:315-320.
2011
-
Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI dynamic registry).
108:1658-1664.
2011
-
Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study).
108:1108-1111.
2011
-
Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from get with the guidelines-heart failure).
107:1818-1823.
2011
-
Quality of life in pediatric patients with implantable cardioverter defibrillators.
107:1023-1027.
2011
-
Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomes.
108:949-954.
2011
-
Reply.
107:143-144.
2011
-
Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007.
108:617-624.
2011
-
The editor's roundtable: Closing the clinical practice gapusing evidence-based treatments for managing lipids.
107:230-242.
2011
-
Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction..
107:259-267.
2011
-
Impact of recovery of renal function on long-term mortality after coronary artery bypass grafting..
106:1728-1734.
2010
-
Comparison of outcomes in patients aged <75, 75 to 84, and ≥ 85 years with ST-elevation myocardial infarction (from the ACTION Registry-GWTG)..
106:1382-1388.
2010
-
Reply.
106:601-602.
2010
-
Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy)..
106:180-186.
2010
-
Comparison of outcomes among moderate alcohol drinkers before acute myocardial infarction to effect of continued versus discontinuing alcohol intake after the infarct..
105:1651-1654.
2010
-
Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure..
105:1794-1797.
2010
-
Long-term outcomes of medicare beneficiaries with worsening renal function during hospitalization for heart failure..
105:1786-1793.
2010
-
Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention..
105:1065-1069.
2010
-
Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)..
105:667-671.
2010
-
Effect of motorized scooters on quality of life and cardiovascular risk..
105:672-676.
2010
-
N-terminal pro-brain natriuretic peptide and outcomes in patients undergoing surgical ventricular restoration..
105:640-644.
2010
-
Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)..
105:445-452.
2010
-
Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia..
105:487-494.
2010
-
Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stents.
106:774-779.
2010
-
Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI)..
105:59-63.
2010
-
Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program)..
105:139-143.
2010
-
Relation of size of secondary ventricles to exercise performance in children after fontan operation.
106:1652-1656.
2010
-
Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
106:630-634.
2010
-
Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)..
104:1457-1464.
2009
-
Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery disease..
104:1624-1630.
2009
-
Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY)..
104:1330-1335.
2009
-
Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome..
104:1324-1329.
2009
-
Incidence, Clinical Presentation and Outcomes of Drug-Eluting Stent Associated Coronary Aneurysms - a Pooled Analysis.
104:144D-144D.
2009
-
Persistent tricuspid regurgitation and its predictor in adults after percutaneous and isolated surgical closure of secundum atrial septal defect..
104:856-861.
2009
-
Aspirin Resistance in healthy drug-naive men versus women (from the Heredity and Phenotype Intervention Heart Study)..
104:606-612.
2009
-
Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis..
104:525-530.
2009
-
Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry)..
104:507-513.
2009
-
Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome..
104:175-181.
2009
-
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial)..
104:151-157.
2009
-
Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke..
104:287-291.
2009
-
Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease..
103:1518-1524.
2009
-
Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting..
103:1546-1550.
2009
-
Role of frailty in patients with cardiovascular disease..
103:1616-1621.
2009
-
Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION])..
103:1285-1289.
2009
-
Characteristics and in-hospital outcomes of patients with cardiac tamponade complicating type A acute aortic dissection..
103:1029-1031.
2009
-
Door-to-balloon times in hospitals within the get-with-the-guidelines registry after initiation of the door-to-balloon (D2B) Alliance..
103:1051-1055.
2009
-
Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry)..
103:766-771.
2009
-
Advances in antiplatelet therapy: agents in clinical development..
103:40A-51A.
2009
-
Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes..
103:295-300.
2009
-
Association of weight change with subsequent outcomes in patients hospitalized with acute decompensated heart failure..
103:76-81.
2009
-
Comparison of Echocardiographic and Cardiac Magnetic Resonance Imaging Measurements of Functional Single Ventricular Volumes, Mass, and Ejection Fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study).
104:419-428.
2009
-
Impact of Gender and Antithrombin Strategy on Early and Late Clinical Outcomes in Patients With Non-ST-Elevation Acute Coronary Syndromes (from the ACUITY Trial).
103:1196-1203.
2009
-
Incidence and Predictors of Stroke Associated With Percutaneous Coronary Intervention.
104:349-353.
2009
-
Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients..
103:124-129.
2009
-
Relation of Corneal Arcus to Cardiovascular Disease (from the Framingham Heart Study Data Set).
103:64-66.
2009
-
ST Resolution 1 Hour After Fibrinolysis for Prediction of Myocardial Infarct Size: Insights from ASSENT 3.
103:154-158.
2009
-
Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE]).
103:175-180.
2009
-
Usefulness of Hand-Carried Ultrasound to Predict Elevated Left Ventricular Filling Pressure.
103:246-247.
2009
-
Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure)..
102:1524-1529.
2008
-
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)..
102:1427-1432.
2008
-
Comparison of the impact of short (<1 year) and long-term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality..
102:1159-1162.
2008
-
Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative)..
102:1335-1340.
2008
-
Profile of chronic and recurrent angina pectoris in a referral population..
102:1301-1306.
2008
-
Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial)..
102:1285-1290.
2008
-
Defining optimal research study design for cardiovascular imaging using computed tomography angiography as a model..
102:943-948.
2008
-
Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry)..
102:883-889.
2008
-
Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing)..
102:712-717.
2008
-
Hepatocellular carcinoma with intracavitary cardiac involvement: a case report and review of the literature..
102:643-645.
2008
-
Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV)..
102:546-551.
2008
-
Implementing critical pathways and a multidisciplinary team approach to cardiovascular disease management..
102:47G-56G.
2008
-
Is coding for myocardial infarction more accurate now that coding descriptions have been clarified to distinguish ST-elevation myocardial infarction from non-ST elevation myocardial infarction?.
102:513-517.
2008
-
Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials)..
102:552-558.
2008
-
Weekend/holiday versus weekday hospital discharge and guideline adherence (from the American Heart Association's Get with the Guidelines--Coronary Artery Disease database)..
102:663-667.
2008
-
Emerging role of myocardial perfusion imaging to evaluate patients for cardiac resynchronization therapy..
102:211-217.
2008
-
Risk prediction of coronary heart disease based on retinal vascular caliber (from the Atherosclerosis Risk In Communities [ARIC] Study)..
102:58-63.
2008
-
The editor's roundtable: B-type natriuretic peptide..
101:1733-1740.
2008
-
Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital..
101:1134-1141.
2008
-
Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus..
101:925-929.
2008
-
Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery..
101:1112-1118.
2008
-
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study)..
101:607-612.
2008
-
Meta-analysis comparing reported frequency of atrial fibrillation after acute coronary syndromes in Asians versus whites..
101:506-509.
2008
-
Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure..
101:49-55.
2008
-
Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure..
101:67-71.
2008
-
Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms..
101:29-38.
2008
-
Biology of the natriuretic peptides..
101:3-8.
2008
-
Factors associated with off-label use of drug-eluting stents in patients with ST-elevation myocardial infarction..
101:286-292.
2008
-
Importance and interpretation of intermediate (gray zone) amino-terminal pro-B-type natriuretic peptide concentrations..
101:39-42.
2008
-
The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level..
101:43-48.
2008
-
Understanding amino-terminal pro-B-type natriuretic peptide in obesity..
101:89-94.
2008
-
Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry)..
101:223-230.
2008
-
Impact of Home Warfarin Use on the Treatment and Outcomes of Patients Undergoing Percutaneous Coronary Intervention.
101:1413-1417.
2008
-
Influence of Hospital Length of Stay for Heart Failure on Quality of Care.
102:1693-1697.
2008
-
International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes..
101:25-29.
2008
-
Relation Between Previous Lipid-Lowering Therapy and Infarct Size (Creatine Kinase-MB Level) in Patients Presenting With Acute Myocardial Infarction.
102:1119-1124.
2008
-
The Editor's Roundtable: Lipid Management Beyond Statins-Reducing Residual Cardiovascular Risk.
102:559-567.
2008
-
The Editor's Roundtable: Management and Treatment of Non-ST-Segment Elevation in Acute Coronary Syndromes.
101:1580-1598.
2008
-
Usefulness of Quantitative Versus Qualitative ST-Segment Depression for Risk Stratification of Non-ST Elevation Acute Coronary Syndromes in Contemporary Clinical Practice.
101:919-924.
2008
-
Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: safety, tolerability, and therapeutic potential..
100:27P-32P.
2007
-
Exercise training amount and intensity effects on metabolic syndrome (from Studies of a Targeted Risk Reduction Intervention through Defined Exercise)..
100:1759-1766.
2007
-
Patterns and implications of B-type natriuretic peptide measurement in patients with non-ST-segment elevation acute coronary syndromes..
100:1727-1733.
2007
-
Clinical and angiographic correlates of short- and long-term mortality in patients undergoing coronary artery bypass grafting..
100:1538-1542.
2007
-
Effectiveness and safety of reduced-dose enoxaparin in non-ST-segment elevation acute coronary syndrome followed by antiplatelet therapy alone for percutaneous coronary intervention..
100:1376-1382.
2007
-
Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database..
100:1331-1335.
2007
-
Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial)..
100:1427-1433.
2007
-
Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study)..
100:1336-1340.
2007
-
Antiplatelet Therapy After Implantation of Drug-Eluting Stents: Duration, Resistance, Alternatives, and Management of Surgical Patients.
100.
2007
-
The relation between clinical features, angiographic findings, and the target lesion revascularization rate in patients receiving the endeavor zotarolimus-eluting stent for treatment of native coronary artery disease: an analysis of ENDEAVOR I, ENDEAVOR II, ENDEAVOR II Continued Access Registry, and ENDEAVOR III..
100:62M-70M.
2007
-
Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials)..
100:1047-1051.
2007
-
Impact of delay in door-to-needle time on mortality in patients with ST-segment elevation myocardial infarction..
100:1227-1232.
2007
-
Ethnic differences in coronary artery calcium in a healthy cohort aged 60 to 69 years..
100:981-985.
2007
-
Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of .
100:924-929.
2007
-
The Editor's Roundtable: arterial thrombosis and acute coronary syndromes..
100:974-980.
2007
-
Comparison of baseline characteristics, treatment patterns, and in-hospital outcomes of Asian versus non-Asian white Americans with non-ST-segment elevation acute coronary syndromes from the CRUSADE quality improvement initiative..
100:391-396.
2007
-
Comparison of survival among patients with connective tissue disease and cardiomyopathy (systemic sclerosis, systemic lupus erythematosus, and undifferentiated disease)..
100:513-517.
2007
-
Utility of tissue Doppler and strain echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy..
100:507-512.
2007
-
Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial)..
100:206-210.
2007
-
Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT)..
100:76-83.
2007
-
Evolving role of multidetector computed tomography in evaluation of arrhythmogenic right ventricular dysplasia/cardiomyopathy..
100:99-105.
2007
-
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: Design and methods.
99.
2007
-
Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial..
99:34i-43i.
2007
-
Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial)..
99:1680-1686.
2007
-
Patterns of aspirin dosing in non-ST-elevation acute coronary syndromes in the CRUSADE Quality Improvement Initiative..
99:1496-1499.
2007
-
Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative)..
99:1222-1226.
2007
-
Comparison of in-hospital outcomes of patients with versus without previous carotid endarterectomy undergoing carotid stenting (from the German ALKK CAS Registry)..
99:1288-1293.
2007
-
Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry)..
99:1212-1215.
2007
-
Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes..
99:1351-1356.
2007
-
Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE)..
99:1389-1393.
2007
-
Relation between leucocyte count, myonecrosis, myocardial perfusion, and outcomes following primary angioplasty..
99:1067-1071.
2007
-
Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial)..
99:1055-1061.
2007
-
Usefulness of ST Depression With T-Wave Inversion in Leads V4 to V6 for Predicting One-Year Mortality in Non-ST-Elevation Acute Coronary Syndrome (from the Electrocardiographic Analysis of the Global Use of Strategies to Open Occluded Coronary Arteries IIB Trial).
99:934-938.
2007
-
Usefulness of ST depression with T-wave inversion in leads V(4) to V(6) for predicting one-year mortality in non-ST-elevation acute coronary syndrome (from the Electrocardiographic Analysis of the Global Use of Strategies to Open Occluded Coronary Arteries IIB Trial)..
99:934-938.
2007
-
Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke..
99:1E-35E.
2007
-
Effect of anger provocation on endothelium-dependent and -independent vasodilation..
99:860-863.
2007
-
Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock..
99:793-796.
2007
-
Role of lifestyle and oral anti-diabetic agents to prevent type 2 diabetes mellitus and cardiovascular disease..
99:726-731.
2007
-
Safety considerations with niacin therapy..
99:22C-31C.
2007
-
Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR)..
99:357-363.
2007
-
Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial)..
99:315-321.
2007
-
Trends in operator and hospital procedure volume and outcomes for percutaneous transluminal coronary angioplasty, 1996 to 2001..
99:339-343.
2007
-
Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives..
99:256-260.
2007
-
A Comparison by Medicine Residents of Physical Examination Versus Hand-Carried Ultrasound for Estimation of Right Atrial Pressure.
99:1614-1616.
2007
-
Comparison of effectiveness of enoxaparin versus unfractionated heparin to reduce silent and clinically apparent acute myocardial infarction in patients presenting with non-ST-segment elevation acute coronary syndrome..
99:186-188.
2007
-
Diagnostic Usefulness and Prognostic Implications of the Mitral E/E′ Ratio in Patients With Heart Failure and Severe Secondary Mitral Regurgitation.
100:860-865.
2007
-
Differences Between Local Hospital and Core Laboratory Interpretation of the Admission Electrocardiogram in Patients With Acute Coronary Syndromes and Their Relation to Outcome.
100:169-174.
2007
-
Exercise-Induced Hypertension, Endothelial Dysfunction, and Coronary Artery Disease in a Marathon Runner.
99:743-744.
2007
-
Relation Between Number of Component Views and Accuracy of Left Ventricular Mass Determined by Three-Dimensional Echocardiography.
99:1321-1324.
2007
-
Safety Considerations with Gastrointestinally Active Lipid-Lowering Drugs.
99:S47-S55.
2007
-
Usefulness of routine unfractionated heparin infusion following primary percutaneous coronary intervention for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa inhibitors..
99:202-207.
2007
-
Patterns of guideline adherence and care delivery for patients with unstable angina and non-ST-segment elevation myocardial infarction (from the CRUSADE Quality Improvement Initiative)..
98:30Q-35Q.
2006
-
Effectiveness of prehospital wireless transmission of electrocardiograms to a cardiologist via hand-held device for patients with acute myocardial infarction (from the Timely Intervention in Myocardial Emergency, NorthEast Experience [TIME-NE])..
98:1160-1164.
2006
-
Periannular complications in infective endocarditis involving native aortic valves..
98:1254-1260.
2006
-
Periannular complications in infective endocarditis involving prosthetic aortic valves..
98:1261-1268.
2006
-
Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE)..
98:1172-1176.
2006
-
Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes..
98:624-627.
2006
-
Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department..
98:800-805.
2006
-
Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trial..
98:739-742.
2006
-
Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial)..
98:331-337.
2006
-
Prevalence and predictors of angina pectoris one month after myocardial infarction..
98:282-288.
2006
-
Recognition and treatment of depression and anxiety in patients with acute myocardial infarction..
98:319-324.
2006
-
Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure..
98:386-390.
2006
-
Efficacy of Azmilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease.
98:215-218.
2006
-
From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report..
98:2H-15H.
2006
-
Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting..
98:42-47.
2006
-
Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes..
97:1707-1712.
2006
-
Relation of ventricular premature complexes during recovery from a myocardial perfusion exercise stress test to myocardial ischemia..
97:1570-1572.
2006
-
Cardiovascular disease risk stratification with stress single-photon emission computed tomography technetium-99m tetrofosmin imaging in patients with the metabolic syndrome and diabetes mellitus..
97:1538-1544.
2006
-
Comparison of long-term (seven year) outcomes among patients undergoing percutaneous coronary revascularization with versus without stenting..
97:1467-1472.
2006
-
On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR])..
97:1478-1481.
2006
-
Retinal arterial signs and coronary heart disease..
97:1549.
2006
-
Benefit versus risk in statin treatment..
97:95C-97C.
2006
-
Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force..
97:89C-94C.
2006
-
Feasibility and variability of three dimensional echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy..
97:703-709.
2006
-
Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria..
97:882-885.
2006
-
Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry..
97:538-543.
2006
-
Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUSADE Initiative)..
97:437-442.
2006
-
Statin Safety: An Assessment Using an Administrative Claims Database.
97:S61-S68.
2006
-
Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy)..
97:167-172.
2006
-
Outcomes of patients consented but not randomized in a trial of primary percutaneous coronary intervention in acute myocardial infarction (the CADILLAC registry)..
96:1649-1655.
2005
-
Implications of periaortic hematoma in patients with acute aortic dissection (from the International Registry of Acute Aortic Dissection)..
96:1734-1738.
2005
-
Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes..
96:1200-1206.
2005
-
Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery..
96:1254-1259.
2005
-
Clinical characteristics and outcome of aortic endocarditis with periannular abscess in the International Collaboration on Endocarditis Merged Database..
96:976-981.
2005
-
In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score..
96:913-916.
2005
-
Outcomes by race and etiology of patients with left ventricular systolic dysfunction..
96:956-963.
2005
-
Overview of current noninodilator therapies for acute heart failure syndromes..
96:41G-46G.
2005
-
Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II)..
96:691-695.
2005
-
Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes..
96:750-755.
2005
-
The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF)..
96:18G-25G.
2005
-
Risk factors for cerebrovascular events following fontan palliation in patients with a functional single ventricle..
96:587-591.
2005
-
Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction..
96:325-331.
2005
-
Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction..
96:474-481.
2005
-
Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction..
96:177-182.
2005
-
Combined use of amino terminal-pro-brain natriuretic peptide levels and QRS duration to predict left ventricular systolic dysfunction in patients with dyspnea..
96:263-266.
2005
-
Electrocardiographic findings over time in arrhythmogenic right ventricular dysplasia/cardiomyopathy..
96:122-126.
2005
-
Hostility, age, and mortality in a sample of cardiac patients..
96:64-66.
2005
-
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes..
95:1404-1408.
2005
-
Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapy..
95:1371-1375.
2005
-
Diabetes-related knowledge, atherosclerotic risk factor control, and outcomes in acute coronary syndromes..
95:1290-1294.
2005
-
Meta-analysis of survival and relief of angina pectoris after transmyocardial revascularization..
95:1243-1245.
2005
-
Outcomes following elective percutaneous coronary intervention without on-site surgical backup in a community hospital..
95:1091-1093.
2005
-
Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes..
95:976-978.
2005
-
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study..
95:948-954.
2005
-
Aspirin resistance and a single gene..
95:805-808.
2005
-
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)..
95:611-614.
2005
-
Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy..
95:558-564.
2005
-
Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)..
95:614-618.
2005
-
Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction..
95:383-386.
2005
-
Lipid management in patients with unstable angina pectoris and non-ST-segment elevation acute myocardial infarction (from CRUSADE)..
95:483-485.
2005
-
Design of the SHock Inhibition Evaluation with Azimilide (SHIELD) study: a novel method to assess antiarrhythmic drug effect in patients with an implantable cardioverter-defibrillator..
95:274-276.
2005
-
Clinical characteristics of hypotension in patients with acute aortic dissection.
95:48-52.
2005
-
Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system..
95:8-12.
2005
-
Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial)..
95:1-7.
2005
-
Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery disease..
95:182-188.
2005
-
Relation of impaired Thrombolysis in Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction.
95:224-227.
2005
-
Short- and long-term outcomes of patients with electrocardiographic left ventricular hypertrophy after fibrinolysis for acute myocardial infarction.
96:1050-1052.
2005
-
Simplified peak power reserve in patients with an implantable cardioverter-defibrillator and advanced heart failure.
95:286-288.
2005
-
Assessment of derived 12-lead electrocardiograms using general and patient-specific reconstruction strategies at rest and during transient myocardial ischemia..
94:1529-1533.
2004
-
Comparison of eight- versus 16-slice multidetector-row computed tomography for visibility and image quality of coronary segments.
94:1539-1543.
2004
-
Association between exercise capacity and left ventricular geometry in overweight patients with mild systemic hypertension..
94:1322-1325.
2004
-
Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarction..
94:1029-1033.
2004
-
Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality..
94:879-881.
2004
-
Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy)..
94:926-929.
2004
-
Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial)..
94:983-988.
2004
-
Association of race with complications and prognosis following acute coronary syndromes..
94:792-794.
2004
-
Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?.
94:797-800.
2004
-
Magnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial)..
94:637-A9.
2004
-
Prognostic value of dobutamine stress echocardiography in patients with systemic hypertension and known or suspected coronary artery disease..
94:733-739.
2004
-
Comparison of aortic dissection in patients with and without Marfan's syndrome (results from the International Registry of Aortic Dissection)..
94:400-402.
2004
-
Comparison of low risk and higher risk profiles in middle age to frequency and quantity of coronary artery calcium years later..
94:367-369.
2004
-
Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3)..
94:279-283.
2004
-
Usefulness of spironolactone in a specialized heart failure clinic..
94:443-447.
2004
-
Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality..
94:190-192.
2004
-
A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial..
94:222-227.
2004
-
Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions..
94:30-34.
2004
-
In-hospital mortality associated with the use of intra-aortic balloon counterpulsation..
94:181-185.
2004
-
One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry)..
94:25-29.
2004
-
Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion..
93:1362-A6.
2004
-
Effect of multielement intravascular ultrasound on the anticoagulant potency of enoxaparin..
93:1453-A12.
2004
-
Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia..
93:1487-1494.
2004
-
Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial)..
93:1436-A10.
2004
-
Effects of daily stress on autonomic cardiac control in patients with coronary artery disease..
93:1292-1294.
2004
-
Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left ventricular dysfunction undergoing revascularization..
93:1275-1279.
2004
-
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure..
93:74B-76B.
2004
-
Effects of amino acid supplementation on left ventricular remodeling in patients with chronic heart failure with decreased systolic function and diabetes mellitus: rationale and design of a magnetic resonance imaging study..
93:44A-46A.
2004
-
Final results of the ReoPro readministration registry..
93:979-984.
2004
-
Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial..
93:843-847.
2004
-
Usefulness of percutaneous balloon mitral commissurotomy in preventing the development of atrial fibrillation in patients with mitral stenosis..
93:936-939.
2004
-
Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure..
93:783-785.
2004
-
Comparison of visibility and diagnostic capability of noninvasive coronary angiography by eight-slice multidetector-row computed tomography versus conventional coronary angiography.
93:537-542.
2004
-
Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study)..
93:636-639.
2004
-
Heart rate variability in atrial fibrillation related to left atrial size.
93:705-709.
2004
-
Prognostic usefulness of left ventricular thrombus by echocardiography in dilated cardiomyopathy in predicting stroke, transient ischemic attack, and death..
93:500-503.
2004
-
Computerized QT dispersion measurement and cardiovascular mortality in male veterans.
93:483-486.
2004
-
Relation between late patency of the infarct-related artery, left ventricular function, and clinical outcomes after primary percutaneous intervention for acute myocardial infarction (CADILLAC trial)..
93:349-353.
2004
-
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial)..
93:458-461.
2004
-
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia.
94:795-797.
2004
-
Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?.
93:154-158.
2004
-
Depression as a risk factor for mortality after acute myocardial infarction..
92:1277-1281.
2003
-
Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome..
92:1271-1276.
2003
-
American Journal of Cardiology: Introduction.
92.
2003
-
Outcomes following bail-out abciximab administration during primary intervention in acute myocardial infarction (The CADILLAC Trial)..
92:1091-1094.
2003
-
Outcomes of bail-out stenting for suboptimal balloon angioplasty during primary intervention in acute myocardial infarction (The CADILLAC trial)..
92:1095-1098.
2003
-
Usefulness of frequent arrhythmias after epicardial recanalization in anterior wall acute myocardial infarction as a marker of cellular injury leading to poor recovery of left ventricular function..
92:1143-1149.
2003
-
Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation..
92:941-946.
2003
-
Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial)..
92:779-784.
2003
-
Complications arising after implantation of DDD pacemakers: the MOST experience..
92:740-741.
2003
-
Effect of smoking and sedentary behavior on the association between depressive symptoms and mortality from coronary heart disease..
92:529-532.
2003
-
Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions..
92:651-655.
2003
-
Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial)..
92:660-664.
2003
-
Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure..
92:625-628.
2003
-
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)..
92:330-333.
2003
-
Comparison of 30-day outcome, resource use, and coronary artery disease severity in patients with suspected coronary artery disease with and without diabetes mellitus assigned to chest pain units..
91:1228-1230.
2003
-
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: Review of trials and practical considerations.
91:18-40.
2003
-
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations..
91:18F-40F.
2003
-
Durability of platelet inhibition by clopidogrel..
91:1123-1125.
2003
-
Factors associated with ventricular inducibility in the MADIT-II study population..
91:1002-A7.
2003
-
Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes..
91:936-940.
2003
-
Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure..
91:538-543.
2003
-
Comparison of one-year outcomes .... ESPRIT - Reply.
91:515-515.
2003
-
Comparison of one-year outcomes...ESPRIT. Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy..
91:514-515.
2003
-
Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy..
91:457-461.
2003
-
Time-dependent predictors of primary cardiac arrest in patients with acute myocardial infarction..
91:280-286.
2003
-
Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure..
91:169-174.
2003
-
Efficacy and safety of minimal dose (.
91:1-5.
2003
-
Efficacy and safety of minimal dose (< or =1,000 units) unfractionated heparin with abciximab in percutaneous coronary intervention..
91:1-5.
2003
-
Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000..
91:91-94.
2003
-
Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial)..
91:17-21.
2003
-
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone..
90:1374-1377.
2002
-
Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial)..
90:1246-1249.
2002
-
Comparison of the ability of paramedics with that of cardiologists in diagnosing ST-segment elevation acute myocardial infarction in patients with acute chest pain..
90:995-998.
2002
-
Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT)..
90:916-921.
2002
-
Abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile..
90:628-630.
2002
-
Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial)..
90:585-590.
2002
-
Seeking the optimal aspirin dose in acute coronary syndromes..
90:622-625.
2002
-
Effect of loading with clopidogrel at the time of coronary stenting on platelet aggregation and glycoprotein IIb/IIIa expression and platelet-leukocyte aggregate formation..
90:312-315.
2002
-
Relation of platelet activation and myocardial ischemia biomarkers dependent on type of chest pain (abrupt onset versus intermittent) in patients with angina pectoris or non-Q-wave acute myocardial infarction..
90:310-312.
2002
-
Thresholds for the electrocardiographic change range of biochemical markers of acute myocardial infarction (GUSTO-IIa data)..
90:233-237.
2002
-
Elucidation of the molecular mechanism of action of selective estrogen receptor modulators.
90:35F-43F.
2002
-
Elucidation of the molecular mechanism of action of selective estrogen receptor modulators.
90:F35-F43.
2002
-
Elucidation of the molecular mechanism of action of selective estrogen receptor modulators..
90:35F-43F.
2002
-
Comparison of cardiac marker concentrations in healthy blood donors and hospital patients without acute coronary syndrome..
90:177-178.
2002
-
Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank)..
90:101-107.
2002
-
Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox)..
90:42-45.
2002
-
Patient-reported frequency of taking aspirin in a population with coronary artery disease..
89:1042-1046.
2002
-
Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy..
89:993-995.
2002
-
Changes in hemodynamics and left ventricular structure after menopause..
89:830-833.
2002
-
Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry)..
89:791-796.
2002
-
The coxib story: some lessons and more questions..
89:971-972.
2002
-
Iatrogenic aortic dissection..
89:623-626.
2002
-
Underuse of aspirin in a referral population with documented coronary artery disease..
89:653-661.
2002
-
In-hospital costs of coronary stent implantation with and without Eptifibatide (The ESPRIT Trial).
89:61-64.
2002
-
In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin..
89:61-64.
2002
-
Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia*.
89:672-678.
2002
-
Usefulness of psychosocial treatment of mental stress-induced myocardial ischemia in men..
89:164-168.
2002
-
Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention..
88:1403-A6.
2001
-
Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non-ST-segment elevation acute myocardial infarction..
88:1230-1234.
2001
-
Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-Trial..
88:1240-1245.
2001
-
Testing an intervention to increase cardiac rehabilitation enrollment after coronary artery bypass grafting..
88:1415-A6.
2001
-
Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study)..
88:1097-1102.
2001
-
Comparison of results of percutaneous balloon mitral commissurotomy in patients aged > or = 65 years with those in patients aged < 65 years..
88:994-1000.
2001
-
Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT--(Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II Trial..
88:969-973.
2001
-
Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy..
88:987-993.
2001
-
Comparison of primary coronary angioplasty versus thrombolysis in patients with ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogram..
88:842-847.
2001
-
Does "Optimal" percutaneous transluminal coronary angioplasty (PTCA) provide equivalent outcomes in acute myocardial infarction (AMI) compared with stenting? Insights from the CADILLAC trial..
88:27G-27G.
2001
-
Does primary stenting benefit proximal LAD infarction? The CADILLAC trial..
88:64G-64G.
2001
-
Outcomes in elderly patients undergoing primary coronary intervention for AMI: Insights from the CADILLAC trial..
88:64G-65G.
2001
-
A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris..
88:488-492.
2001
-
Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS)..
88:541-546.
2001
-
Refractory systemic hypertension following type B aortic dissection..
88:686-688.
2001
-
Association of noninvasive markers of coronary artery reperfusion to assess microvascular obstruction in patients with acute myocardial infarction treated with primary angioplasty..
88:342-346.
2001
-
Comparison of self-expanding and balloon-expandable stents for the reduction of restenosis..
88:253-259.
2001
-
Effect of gender on the outcomes of contemporary percutaneous coronary intervention..
88:359-364.
2001
-
Enhancing recovery in coronary heart disease (ENRICHD): baseline characteristics..
88:316-322.
2001
-
Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction..
88:170-A6.
2001
-
Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial..
88:A7-79.
2001
-
Effects of kaliuretic peptide on sodium and water excretion in persons with congestive heart failure..
88:23-29.
2001
-
Fractal correlation properties of heart rate dynamics and adverse events in patients with implantable cardioverter-defibrillators..
88:17-22.
2001
-
Effect of Eptifibatide on coronary flow reserve following coronary stent implantation (An ESPRIT substudy).
87:1293-1295.
2001
-
Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy..
87:1293-1295.
2001
-
Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease..
87:1398-1400.
2001
-
Association between selective serotonin-reuptake inhibitor therapy and heart valve regurgitation..
87:989-93: A4.
2001
-
Significance of recurrent pain in acute type B aortic dissection..
87:930-933.
2001
-
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes.
87:532-536.
2001
-
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy..
87:532-536.
2001
-
Relation of soluble and platelet P-selectin to early outcome in patients with acute myocardial infarction after thrombolytic therapy..
87:774-7, A7.
2001
-
Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project)..
87:272-277.
2001
-
Effectiveness and safety of abciximab after failed thrombolytic therapy..
87:439-A4.
2001
-
Usefulness of diabetic retinopathy as a marker of risk for thallium myocardial perfusion defects in non-insulin-dependent diabetes mellitus..
87:456-9, A6.
2001
-
Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2]).
88:107-111.
2001
-
Effect of increased body mass index on accuracy of two-dimensional echocardiography for measurement of left ventricular volume, ejection fraction, and mass.
87:371-374.
2001
-
Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function.
87:716-720.
2001
-
Gradient and spin echo(cardiographic) magnetic resonance imaging: Prevalence of descriptive errors in published articles.
88:92-94.
2001
-
The relevance of tissue angiotensin-converting enzyme: Manifestations in mechanistic and endpoint data.
88:1L-20L.
2001
-
Strategies of patient care in acute coronary syndromes: rationale for the Global Registry of Acute Coronary Events (GRACE) registry..
86:4M-9M.
2000
-
Comparison of medicine alone, coronary angioplasty, and left internal mammary artery-coronary artery bypass for one-vessel proximal left anterior descending coronary artery disease..
86:1322-1326.
2000
-
Robust benefit of glycoprotein IIb/IIIa inhibition with eptifibatide in patients undergoing stent percutaneous coronary intervention with positive cardiac markers at baseline..
86:13I-14I.
2000
-
Clinical and electrocardiographic variables associated with increased risk of ventricular septal defect in acute anterior myocardial infarction..
86:830-834.
2000
-
Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function..
86:863-867.
2000
-
Costs of revascularization over eight years in the randomized and eligible patients in the Emory Angioplasty versus Surgery Trial (EAST)..
86:747-752.
2000
-
Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes..
86:713-717.
2000
-
Moderators of the effect of social support on depressive symptoms in cardiac patients..
86:438-442.
2000
-
A prospective study of dominance and coronary heart disease in the Normative Aging Study..
86:145-149.
2000
-
Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial)..
86:24-29.
2000
-
Association of chronic congestive heart failure in humans with an intrinsic upregulation in skeletal muscle sarcoplasmic reticulum calcium ion adenosine triphosphatase activity..
85:1498-1500.
2000
-
Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris..
85:1414-1419.
2000
-
Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure..
85:1110-1113.
2000
-
Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia..
85:1100-1105.
2000
-
The benefit of abciximab in percutaneous coronary revascularization is not device-specific..
85:1060-1064.
2000
-
The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: Current practice and future trends.
85:32-38.
2000
-
Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit..
85:801-805.
2000
-
The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends..
85:32C-38C.
2000
-
A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes..
85:692-697.
2000
-
Applying the resource-based relative value scale to the Emory angioplasty versus surgery trial..
85:685-691.
2000
-
Quality of life after coronary revascularization in the United States and Canada..
85:548-553.
2000
-
Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group..
85:543-547.
2000
-
Outcomes following interventions in small coronary arteries with the use of hand-crimped Palmaz-Schatz stents..
85:446-450.
2000
-
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II).
85:427-434.
2000
-
Efficacy of abciximab readministration in coronary intervention..
85:435-440.
2000
-
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis..
85:427-434.
2000
-
Strategies of patient care in acute coronary syndromes: rationale for the Global Registry of Acute Coronary Events (GRACE) registry..
86:4-9.
2000
-
Prognostic value of thallium-201 single-photon emission computed tomography for patients with multivessel coronary artery disease after revascularization (the Emory Angioplasty versus Surgery Trial [EAST])..
84:1369-1374.
1999
-
Real-time three-dimensional echocardiography for measurement of left ventricular volumes..
84:1434-1439.
1999
-
Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study)..
84:1311-1316.
1999
-
Lack of effect of increased inspired oxygen concentrations on maximal exercise capacity or ventilation in stable heart failure..
84:1412-1416.
1999
-
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries..
84:1281-1286.
1999
-
Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (Results from the GUSTO-III trial).
84:779-784.
1999
-
Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteries..
84:779-784.
1999
-
Abciximab reduces in-hospital events among patients undergoing percutaneous coronary intervention..
84:67P-67P.
1999
-
Abciximab reduces procedure time among patients undergoing percutaneous coronary intervention..
84:71P-71P.
1999
-
Terminal QRS distortion on admission is better than ST-segment measurements in predicting final infarct size and assessing the Potential effect of thrombolytic therapy in anterior wall acute myocardial infarction..
84:530-534.
1999
-
Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors..
84:321-3, A8.
1999
-
Coronary artery restenosis after atherectomy is primarily due to negative remodeling..
84:141-146.
1999
-
Can cardiovascular clinical characteristics be identified and outcome models be developed from an in-patient claims database?.
84:166-169.
1999
-
Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment.
83:7-11.
1999
-
Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment..
83:7E-11E.
1999
-
Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure..
83:1345-1349.
1999
-
Echocardiographic characteristics of successful deployment of the Das AngelWings atrial septal defect closure device: initial multicenter experience in the United States..
83:1236-1241.
1999
-
Prior aspirin use predicts worse outcomes in patients with non-ST- elevation acute coronary syndromes.
83:1147-1151.
1999
-
Cardiac troponin T and I, echocardiographic [correction of electrocardiographic] wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon..
83:1085-1089.
1999
-
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy..
83:1147-1151.
1999
-
Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplasty..
83:675-680.
1999
-
Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial..
83:317-322.
1999
-
Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy..
83:482-487.
1999
-
Cardiac troponin T and I, electrocardiographic wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon.
83:1085-1089.
1999
-
Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure..
83:1A-38A.
1999
-
Correlation of angiographic findings and right (V1 to V3) versus left (V4 to V6) precordial ST-segment depression in inferior wall acute myocardial infarction..
83:143-148.
1999
-
Differences between men and women in the management of unstable angina pectoris (the Guarantee Registry).
84:1145-1150.
1999
-
Direct myocardial revascularization and angiogenesis - How many patients might be eligible?.
84:598-600.
1999
-
Dual hepatic metabolism of cerivastatin - Clarifications.
84:497-.
1999
-
Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation.
83:13H-18H.
1999
-
Predictors and significance of atrial rhythm before and six months after percutaneous balloon mitral commissurotomy..
83:125-A9.
1999
-
Thrombosis and the role of the platelet.
83:3E-6E.
1999
-
Advances in dyslipidemia: Discussion session II.
82:85U-86U.
1998
-
Effect of niacin on atherosclerotic cardiovascular disease..
82:18U-23U.
1998
-
Introduction.
82.
1998
-
Treatment of hyperlipidemia with combined niacin-statin regimens..
82:82U-84U.
1998
-
What does the left atrial v wave signify during balloon commissurotomy of mitral stenosis?.
82:1388-1393.
1998
-
Acute hemodynamic changes during carotid artery stenting..
82:1077-1081.
1998
-
Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention..
82:1105-A6.
1998
-
Abciximab benefit in coronary intervention has no gender bias: Results of EPIC, EPILOG and CAPTURE trials..
82:95S-95S.
1998
-
Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial.
82:881-887.
1998
-
Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival Evaluation..
82:881-887.
1998
-
Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia..
82:737-743.
1998
-
Low-molecular-weight heparins in non-ST-segment elevation ischemia: The ESSENCE trial.
82:19L-24L.
1998
-
Diagnosing coronary arterial stent thrombosis and arterial closure..
82:666-A6.
1998
-
Local administration of L-703,081 using a composite polymeric stent reduces platelet deposition in canine coronary arteries..
82:673-A8.
1998
-
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events..
82:19L-24L.
1998
-
Robert McKinnon Califf, MD: a conversation with the editor. Interview by William Clifford Roberts..
82:639-658.
1998
-
Predictors of in-hospital bundle branch block reversion after presenting with acute myocardial infarction and bundle branch block. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries..
82:373-374.
1998
-
Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy.
82:7-12.
1998
-
Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I Substudy).
81:1078-1084.
1998
-
Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries..
81:1078-1084.
1998
-
A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary intervention..
81:970-976.
1998
-
Soluble vascular cell adhesion molecule-1 and E-selectin in patients with acute myocardial infarction treated with thrombolytic agents..
81:772-775.
1998
-
Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial)..
81:632-636.
1998
-
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries..
81:282-287.
1998
-
A new extended-release niacin (niaspan): Efficacy, tolerability, and safety in hypercholesterolemic patients.
82:29U-34U.
1998
-
A perspective on the regulation of the evaluation of new antithrombotic drugs.
82:25P-35P.
1998
-
Causes and consequences of discontinuation of the implantable cardioverter-defibrillator therapy in non-terminally III patients.
81:1203-1205.
1998
-
Effect of niacin on atherosclerotic cardiovascular disease.
82:18U-23U.
1998
-
Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina.
81:678-681.
1998
-
Efficacy and safety of an extended-release niacin (Niaspan): A long- term study.
82:74U-81U.
1998
-
Relation between the number of image planes and the accuracy of three- dimensional echocardiography for measuring left ventricular volumes and ejection fraction.
82:1431-1434.
1998
-
Selecting an antiarrhythmic agent for atrial fibrillation should be a patient-specific, data-driven decision.
82:72N-81N.
1998
-
Treatment of hyperlipidemia with combined niacin-statin regimens.
82:82U-84U.
1998
-
Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial..
81:36-40.
1998
-
Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias..
80:1551-1557.
1997
-
Predictors of acute and long-term outcome with transluminal extraction atherectomy: the New Approaches to Coronary Intervention (NACI) registry..
80:68K-77K.
1997
-
Evaluation and clinical application of a direct low-density lipoprotein cholesterol assay in normolipidemic and hyperlipidemic adults..
80:1295-1299.
1997
-
Left ventricular hypertrophy in athletes..
80:1384-1388.
1997
-
Future horizons in cardiovascular molecular therapeutics..
80:33I-39I.
1997
-
Treatment of hyperlipidemia by specialists versus generalists as secondary prevention of coronary artery disease..
80:1345-1347.
1997
-
Economics of treating heart failure..
80:33H-38H.
1997
-
Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts.
80:985-988.
1997
-
Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. EPIC Investigators. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications..
80:985-988.
1997
-
Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure..
80:808-811.
1997
-
Roundtable panel discussion: The role of glycoprotein IIb-IIIa receptor inhibitors in acute ischemic coronary syndromes.
80.
1997
-
Impact of entifibatide on early ischemic event in acute ischemic coronary syndromes: A review of the IMPACT II trial.
80:21B-28B.
1997
-
Electrocardiographic differentiation of the ST-segment depression of acute myocardial injury due to the left circumflex artery occlusion from that of myocardial ischemia of nonocclusive etiologies..
80:512-513.
1997
-
Impact of eptifibatide on early ischemic events in acute ischemic coronary syndromes: a review of the IMPACT II trial. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis..
80:21B-28B.
1997
-
Role of right ventricular and pulmonary functional abnormalities in limiting exercise capacity in adults with congenital heart disease..
80:315-322.
1997
-
Roundtable panel discussion: the role of glycoprotein IIb-IIIa receptor inhibitors in acute ischemic coronary syndromes..
80:44B-48B.
1997
-
Effect of inadequate cardiac output reserve on exercise tolerance in patients with moderate mitral stenosis..
80:236-240.
1997
-
Adenosine for myocardial protection in acute myocardial infarction.
79:44-48.
1997
-
Adenosine for myocardial protection in acute myocardial infarction..
79:44-48.
1997
-
Angioplasty or surgery for multivessel coronary artery disease: Comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes.
79:1453-1459.
1997
-
Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators..
79:1453-1459.
1997
-
Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial.
79:1232-1235.
1997
-
Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary Arteries..
79:1232-1235.
1997
-
Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction..
79:1118-1120.
1997
-
Association of systolic blood pressure at time of myocardial ischemia with angina pectoris during exercise testing..
79:954-956.
1997
-
Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada.
79:867-872.
1997
-
Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada. Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) and Canadian Coronary Atherectomy Trial (CCAT) investigators..
79:867-872.
1997
-
Usefulness of serial radionuclide angiography in predicting cardiac death after coronary artery bypass grafting and comparison with clinical and cardiac catheterization data..
79:851-855.
1997
-
Impact of diabetes mellitus on percutaneous revascularization (CAVEAT- I).
79:748-755.
1997
-
Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction.
79:590-594.
1997
-
Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intraaortic Balloon Pump..
79:590-594.
1997
-
Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on six-week left ventricular function. The TAMI Investigators. Thrombolysis and Angioplasty in Acute Myocardial Infarction..
79:539-544.
1997
-
Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on six-week left ventricular function. The TAMI Investigators. Thrombolysis and Angioplasty in Acute Myocardial Infarction..
79:539-544.
1997
-
Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I). CAVEAT-I Investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial..
79:748-755.
1997
-
Predicting adverse outcome with exercise SPECT technetium-99m sestamibi imaging in patients with suspected or known coronary artery disease..
79:270-274.
1997
-
Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators..
79:286-291.
1997
-
Blood pressure responses to mental stress in emotionally defensive patients with stable coronary artery disease.
80:343-346.
1997
-
Economics of treating heart failure.
80:33H-38H.
1997
-
Excimer laser coronary angioplasty: The New Approaches to Coronary Intervention (NACI) experience.
80:99K-105K.
1997
-
Introduction.
80.
1997
-
New approaches to cardiovascular therapy: Panel discussion.
80.
1997
-
Predictors of acute and long-term outcome with transluminal extraction atherectomy: The New Approaches to Coronary Intervention (NACI) registry.
80:68K-77K.
1997
-
Who are the MADIT patients?.
80:42F-46F.
1997
-
Evaluation of the effect of transthoracic cardioversion from ventricular tachycardia to sinus rhythm on left atrial mechanical function..
78:1436-1439.
1996
-
A metaanalysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging..
78:1327-1337.
1996
-
Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries..
78:1338-1344.
1996
-
A comparison of debulking versus dilatation of bifurcation coronary arterial narrowings (from the CAVEAT I Trial). Coronary Angioplasty Versus Excisional Atherectomy Trial-I..
78:1039-1041.
1996
-
Is there a bias against performing coronary revascularization in women?.
78:1154-1160.
1996
-
Collagen subtypes III and IV expression in human vein graft atherosclerosis..
78:691-694.
1996
-
Depression and long-term mortality risk in patients with coronary artery disease..
78:613-617.
1996
-
Why cardiologists should be interested in estrogen..
78:559-561.
1996
-
Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective..
78:35-40.
1996
-
Prediction of the infarct-related artery in acute myocardial infarction by a scoring system using summary ST-segment and T-wave changes..
78:389-395.
1996
-
Relation of lumen size to restenosis after percutaneous transluminal coronary balloon angioplasty.
78:221-224.
1996
-
Compression of digital coronary angiograms does not affect visual or quantitative assessment of coronary artery stenosis severity..
78:131-135.
1996
-
Ethnic differences in forearm vasodilator capacity..
78:208-211.
1996
-
Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction..
78:1-8.
1996
-
Relation of lumen size to restenosis after percutaneous transluminal coronary balloon angioplasty.
78:221-224.
1996
-
Relation of lumen size to restenosis after percutaneous transluminal coronary balloon angioplasty. Lovastatin Restenosis Trial Group..
78:221-224.
1996
-
Use of calcium channel antagonists in myocardial revascularization procedures..
77:26D-31D.
1996
-
Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. EPIC investigators..
77:1045-1051.
1996
-
A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. The DUCCS-II Investigators..
77:791-797.
1996
-
Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy..
77:551-556.
1996
-
Negative predictive value of the Duke criteria for infective endocarditis..
77:403-407.
1996
-
Glycoprotein IIb/IIIa receptor inhibitors: Putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective.
78:35-40.
1996
-
How much do we gain by reducing time to reperfusion therapy?.
78:8-15.
1996
-
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB trial).
78:142-147.
1996
-
Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction.
78:1338-1344.
1996
-
Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention..
76:1222-1227.
1995
-
Implications for cost-effectiveness.
76:1182.
1995
-
The way of the future redux..
76:1177-1182.
1995
-
Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study Group..
76:1007-1013.
1995
-
Left ventricular performance improves late after aortic valve replacement in patients with aortic stenosis and reduced ejection fraction..
76:612-615.
1995
-
Relative importance of electrode placement over number of channels in transient myocardial ischemia detection by Holter monitoring..
76:350-354.
1995
-
Importance of baseline functional and socioeconomic factors for participation in cardiac rehabilitation..
76:36-39.
1995
-
Distinguishing between early and late responders to symptoms of acute myocardial infarction..
75:1019-1022.
1995
-
Significance of a coronary artery with Thrombolysis in Myocardial infarction grade 2 flow "patency" (outcome in the Thrombolysis and Angioplasty in Myocardial Infarction trials).
75:871-876.
1995
-
Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group..
75:871-876.
1995
-
Usefulness of ischemic response to mental stress in predicting silent myocardial ischemia during ambulatory monitoring..
75:1007-1011.
1995
-
Coronary anatomic and procedural characteristics of patients randomized to coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI)..
75:27C-33C.
1995
-
Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial).
75:559-562.
1995
-
Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial). Evaluation of c7E3 Fab in the Prevention of Ischemic Complications trial..
75:559-562.
1995
-
Emory Angioplasty Versus Surgery Trial (EAST): design, recruitment, and baseline description of patients..
75:42C-59C.
1995
-
Initial functional and economic status of patients with multivessel coronary artery disease randomized in the Bypass Angioplasty Revascularization Investigation (BARI)..
75:34C-41C.
1995
-
Predictors of outcome of tricuspid valve replacement in carcinoid heart disease..
75:485-488.
1995
-
Left ventricular mass and diastolic filling patterns in quadriplegia and implications for effects of normal aging on the heart.
75:201-203.
1995
-
Multiplane transesophageal echocardiographic assessment of left atrial appendage anatomy and function.
76:528-530.
1995
-
Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm.
75:624-626.
1995
-
Transesophageal echocardiographic assessment of reversal of systolic pulmonary venous flow in mitral stenosis..
75:58-60.
1995
-
A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction..
74:1220-1228.
1994
-
Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgery.
74:1166-1170.
1994
-
Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgery. EPIC Investigators. Evaluation Prevention of Ischemic Complications..
74:1166-1170.
1994
-
Simultaneous ST-segment measurements using standard and monitoring-compatible torso limb lead placements at rest and during coronary occlusion..
74:997-1001.
1994
-
Quality-of-life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia..
74:826-829.
1994
-
Value of transthoracic echocardiography in predicting embolic events in active infective endocarditis. Duke Endocarditis Service..
74:799-801.
1994
-
Hostility in asymptomatic men with angiographically confirmed coronary artery disease..
74:439-442.
1994
-
Importance of ST-segment depression as a determinant of ventricular premature complex frequency after thrombolysis for acute myocardial infarction. Tissue Plasminogen Activator: Toronto (TPAT) Study Group..
74:419-423.
1994
-
Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions.
74:144-148.
1994
-
Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. The Percutaneous Excimer Laser Coronary Angioplasty Registry..
74:144-148.
1994
-
Effects of heparin and cardiac catheterization on serum lipoprotein and triglyceride levels..
74:47-52.
1994
-
Frequency of transient reductions in left ventricular ejection fraction at rest in coronary artery disease..
74:137-143.
1994
-
Comparison of continuous ST-segment recovery analysis with methods using static electrocardiograms for noninvasive patency assessment during acute myocardial infarction.
73:1069-1074.
1994
-
Comparison of continuous ST-segment recovery analysis with methods using static electrocardiograms for noninvasive patency assessment during acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 7 Study Group..
73:1069-1074.
1994
-
Successful use of education and cost-based feedback strategies to reduce physician utilization of low-osmolality contrast agents in the cardiac catheterization laboratory..
73:1219-1221.
1994
-
Frequency of hypothyroidism in adults with serum total cholesterol levels > 200 mg/dl..
73:955-957.
1994
-
A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty..
73:835-839.
1994
-
Does ambulatory monitoring contribute to exercise testing and myocardial perfusion scintigraphy in the prediction of the extent of coronary artery disease in stable angina?.
73:747-752.
1994
-
Double-blind coumadin research--an ethical dilemma..
73:725-726.
1994
-
Primary coronary angioplasty for acute myocardial infarction (the Primary Angioplasty Registry)..
73:627-634.
1994
-
Reply.
73:725-726.
1994
-
An overview of risk assessment in coronary artery disease..
73:19B-25B.
1994
-
Intracranial hemorrhage risk and new thrombolytic therapies in acute myocardial infarction..
73:444-449.
1994
-
Programmed Outcome Research Teams (PORTs) and implications for clinical practice..
73:34B-38B.
1994
-
Right ventricular infarction complicated by acute right-to-left shunting.
74:824-826.
1994
-
Usefulness of dobutamine echocardiography for detecting restenosis after percutaneous transluminal coronary angioplasty..
72:1220-1225.
1993
-
Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody. The TAMI Study Group..
72:1121-1125.
1993
-
Relation of cardiovascular responses to mental stress and cardiac vagal activity in coronary artery disease..
72:551-554.
1993
-
Impact of tissue plasminogen activator and heparin versus heparin alone on quantitative coronary angiographic findings in myocardial infarction. The Toronto Tissue Plasminogen Activator Trial Study Group..
72:379-383.
1993
-
Long-term outcome following successful reopening of abrupt closure after coronary angioplasty..
72:21-25.
1993
-
Ratio of ST-segment and myoglobin slopes to estimate myocardial salvage during thrombolytic therapy for acute myocardial infarction..
71:1362-1365.
1993
-
Treatment of long coronary artery narrowings with long angioplasty balloon catheters..
71:1274-1277.
1993
-
Minimizing the risk of inappropriately administering thrombolytic therapy (Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] study group)..
71:783-787.
1993
-
Relation between pulmonary artery pressure and mitral stenosis severity in patients undergoing balloon mitral commissurotomy..
71:874-878.
1993
-
In vivo validation of compensatory enlargement of atherosclerotic coronary arteries..
71:665-668.
1993
-
Unrecognized left main coronary artery disease in patients undergoing interventional procedures..
71:173-176.
1993
-
Comparison of results of percutaneous balloon valvuloplasty in patients with mild and moderate mitral stenosis to those with severe mitral stenosis.
71:1300-1303.
1993
-
Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations..
71:145-151.
1993
-
Clinical success, complications and restenosis rates with excimer laser coronary angioplasty.
70:1533-1539.
1992
-
Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry..
70:1533-1539.
1992
-
Importance of early and complete reperfusion to achieve myocardial salvage after thrombolysis in acute myocardial infarction..
70:1391-1396.
1992
-
Autocrine and paracrine mechanisms in the pathophysiology of heart failure..
70:4C-11C.
1992
-
Performance status and outcome after coronary artery bypass grafting in persons aged 80 to 93 years..
70:567-571.
1992
-
Angiographic follow-up after internal mammary artery graft angioplasty..
70:401-403.
1992
-
Methodologic issues in clinical evaluation of stenosis severity in adults undergoing aortic or mitral balloon valvuloplasty.
69:1607-1616.
1992
-
Methodologic issues in clinical evaluation of stenosis severity in adults undergoing aortic or mitral balloon valvuloplasty. The NHLBI Balloon Valvuloplasty Registry..
69:1607-1616.
1992
-
Outcome after prolonged balloon inflations of greater than 20 minutes for initially unsuccessful percutaneous transluminal coronary angioplasty..
69:1417-1421.
1992
-
Complex angioplasty: a surgeon's perspective..
69:22F-24F.
1992
-
Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarction..
69:1120-1127.
1992
-
Diagnosis and management (by subxiphoid pericardiotomy) of large pericardial effusions causing cardiac tamponade..
69:1075-1078.
1992
-
Fibrin modification by ionic and nonionic contrast media during cardiac catheterization..
69:821-823.
1992
-
Calibration using angiographic catheters as scaling devices - Importance of filming the catheters not filled with contrast medium.
69:1377-1378.
1992
-
Clinical risks of thrombolytic therapy..
69:12A-20A.
1992
-
Left ventricular filling and ventricular diastolic performance after percutaneous balloon mitral valvotomy..
69:108-112.
1992
-
Thrombin antagonists and antiplatelet agents.
69:A39-A51.
1992
-
Doppler echocardiographic findings in adults with severe symptomatic valvular aortic stenosis.
68:1477-1484.
1991
-
Doppler echocardiographic findings in adults with severe symptomatic valvular aortic stenosis. Balloon Valvuloplasty Registry Echocardiographers..
68:1477-1484.
1991
-
Effect of digoxin on ST-segment changes detected by ambulatory electrocardiographic monitoring in healthy subjects..
68:1503-1506.
1991
-
Doppler assessment of pulmonary artery flow patterns and ventricular function after the Fontan operation..
68:1211-1215.
1991
-
Intracoronary ultrasound evaluation of interventional technologies..
68:1305-1309.
1991
-
Pitfalls in the determination of absolute dimensions using angiographic catheters as calibration devices in quantitative angiography..
68:1176-1182.
1991
-
Comparison of cardiovascular and renal toxicity after cardiac catheterization using a nonionic versus ionic radiographic contrast agent..
68:1117-1119.
1991
-
Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index..
68:973-975.
1991
-
Thrombolytic therapy in patients requiring cardiopulmonary resuscitation..
68:1015-1019.
1991
-
Long-term assessment of right ventricular diastolic filling in patients with pulmonic valve stenosis successfully treated in childhood..
68:648-652.
1991
-
Immunosuppressive therapy and lipoprotein abnormalities after cardiac transplantation..
68:389-391.
1991
-
Frequency of low serum high-density lipoprotein cholesterol levels in hospitalized patients with "desirable" total cholesterol levels..
68:187-192.
1991
-
Determinants of one-year outcome from balloon aortic valvuloplasty..
68:75-80.
1991
-
Percutaneous transluminal coronary angioplasty in octogenarians as an effective therapy for angina pectoris..
68:116-119.
1991
-
Effects of hemoperfusion during percutaneous transluminal coronary angioplasty on left ventricular function..
67:1324-1329.
1991
-
Quantification of ST-segment changes during coronary angioplasty in patients with left bundle branch block..
67:1219-1222.
1991
-
Detection of silent myocardial ischemia in diabetes mellitus..
67:1073-1078.
1991
-
Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias..
67:976-980.
1991
-
Prediction of death and myocardial infarction by radionuclide angiocardiography in patients with suspected coronary artery disease..
67:919-926.
1991
-
Comparison of intravascular ultrasound, external ultrasound and digital angiography for evaluation of peripheral artery dimensions and morphology..
67:817-822.
1991
-
Mechanical failure of a St. Jude Medical prosthesis.
67:906-908.
1991
-
Creation of pseudo narrowing during coronary angioplasty..
67:658-659.
1991
-
Lidocaine toxicity after subcutaneous infiltration in children undergoing cardiac catheterization..
67:647-648.
1991
-
Effects of exercise training on cardiorespiratory function in men and women older than 60 years of age..
67:633-639.
1991
-
Pericardial effusion after intravenous recombinant tissue-type plasminogen activator for acute myocardial infarction..
67:496-500.
1991
-
Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy. TAMI Study Group..
67:225-230.
1991
-
Adjunctive use of beta-adrenergic blockers, calcium antagonists and other therapies in coronary thrombolysis.
67:25-31.
1991
-
Effectiveness of percutaneous balloon mitral valvotomy during pregnancy.
68:930-934.
1991
-
Medical, ethical and legal issues regarding thrombolytic therapy in the Jehovah's Witness.
68:1525-1529.
1991
-
Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction..
66:1407-1411.
1990
-
Relation of angiographic detected intracoronary thrombus and silent myocardial ischemia in unstable angina pectoris..
66:1381-1382.
1990
-
Transient electrocardiographic changes of elective coronary angioplasty compared with evolutionary changes of subsequent acute myocardial infarction observed with continuous three-lead monitoring..
66:1509-1512.
1990
-
Usefulness of a pericardial friction rub after thrombolytic therapy during acute myocardial infarction in predicting amount of myocardial damage. The TAMI Study Group..
66:1418-1421.
1990
-
Simultaneous measurement of myocardial perfusion and ventricular function during exercise from a single injection of technetium-99m sestamibi in coronary artery disease..
66:68E-71E.
1990
-
Selective infusion of thrombolytic therapy in the acute myocardial infarct-related coronary artery as an alternative to rescue percutaneous transluminal coronary angioplasty..
66:1021-1023.
1990
-
Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure..
66:22D-30D.
1990
-
Two-year outcome after angiographically documented myocardial reperfusion for acute coronary occlusion.
66:796-801.
1990
-
Two-year outcome after angiographically documented myocardial reperfusion for acute coronary occlusion. Thrombolysis and Angioplasty Study Group..
66:796-801.
1990
-
Early and late changes in left ventricular systolic performance after percutaneous aortic balloon valvuloplasty..
66:327-332.
1990
-
Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol..
66:279-284.
1990
-
Effect of Type A behavior on exercise test outcome in coronary artery disease..
66:179-182.
1990
-
Detection, characterization and functional assessment of reperfused Q-wave acute myocardial infarction by cine magnetic resonance imaging..
66:1-9.
1990
-
Pulsed Doppler evaluation of right ventricular diastolic filling in children with pulmonary valve stenosis before and after balloon valvuloplasty..
66:79-84.
1990
-
Thrombotic and cardiovascular complications related to nonionic contrast media during cardiac catheterization: analysis of 8,517 patients..
65:1481-1484.
1990
-
Anatomic validation of electrocardiographic estimation of the size of acute or healed myocardial infarcts..
65:1301-1307.
1990
-
Changes in left ventricular systolic performance immediately after percutaneous aortic balloon valvuloplasty..
65:1213-1218.
1990
-
Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia..
65:609-614.
1990
-
Ten-year results with the St. Jude Medical prosthesis..
65:217-225.
1990
-
Aerobic exercise reduces levels of cardiovascular and sympathoadrenal responses to mental stress in subjects without prior evidence of myocardial ischemia..
65:93-98.
1990
-
Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill test..
65:28-34.
1990
-
Effects of sample volume location, imaging view, heart rate and age on tricuspid velocimetry in normal subjects.
65:1026-1030.
1990
-
Failure of balloon aortic valvuloplasty to result in sustained clinical improvement in patients with depressed left ventricular function..
65:72-77.
1990
-
Results of high dose intravenous urokinase for acute myocardial infarction..
65:124-131.
1990
-
The portable programmable microprocessor-driven real-time 12-lead electrocardiographic monitor: a preliminary report of a new device for the noninvasive detection of successful reperfusion or silent coronary reocclusion..
65:143-148.
1990
-
Clinical correlates and prognostic significance of type A behavior and silent myocardial ischemia on the treadmill..
64:1280-1283.
1989
-
Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease..
64:1344-1348.
1989
-
Echocardiographic detection and clinical significance of left atrial vegetations in active infective endocarditis..
64:950-952.
1989
-
Echocardiographic detection of pericardiocentesis-induced subepicardial and intramyocardial hematoma..
64:820-821.
1989
-
Coronary risk associated with age and sex of parental heart disease in the Framingham Study..
64:555-559.
1989
-
Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients..
64:631-635.
1989
-
A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index)..
64:651-654.
1989
-
Type A behavior and survival: a follow-up study of 1,467 patients with coronary artery disease..
64:427-432.
1989
-
Doppler evaluation of homograft valved conduits in children..
64:354-358.
1989
-
Reply.
64:256.
1989
-
Doppler left ventricular diastolic filling abnormalities in aortic stenosis and their relation to hemodynamic parameters..
63:1360-1368.
1989
-
Transient alterations of the QRS complex and ST segment during percutaneous transluminal balloon angioplasty of the right and left circumflex coronary arteries..
63:1208-1213.
1989
-
Quantification of aortic regurgitation after balloon aortic valvuloplasty using videodensitometric analysis of digital subtraction aortography..
63:585-588.
1989
-
Long-term follow-up of patients with echocardiographically detected mitral anular calcium and comparison with age- and sex-matched control subjects..
63:465-470.
1989
-
Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: a qualitative and quantitative angiographic study..
63:423-428.
1989
-
Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis..
63:409-413.
1989
-
Pulsed Doppler assessment of left ventricular diastolic filling in children with left ventricular outflow obstruction before and after balloon angioplasty..
63:231-236.
1989
-
Relation of atrial natriuretic factor to vasoconstrictor hormones and regional blood flow in congestive heart failure..
63:211-216.
1989
-
Cardiac mapping at Duke Medical Center..
63 Suppl:17F-30F.
1989
-
Prevalence of multivalvular regurgitation in athletes.
64:209-212.
1989
-
Severe pulmonary hypertension and cor pulmonale in the acquired immunodeficiency syndrome.
64:1396-1399.
1989
-
Frequency of hypercholesterolemia after cardiac transplantation..
62:1268-1272.
1988
-
Usefulness of exercise electrocardiography and thallium scintigraphy in unstable angina pectoris in predicting the extent and severity of coronary artery disease..
62:1164-1170.
1988
-
Angiographic morphology in unstable angina pectoris..
62:1024-1027.
1988
-
Evaluation of the QRS complex on the standard 12-lead electrocardiogram in normal subjects 70 to 79 years of age..
62:982-985.
1988
-
Transient alterations of the QRS complex and ST segment during percutaneous transluminal balloon angioplasty of the left anterior descending coronary artery..
62:1038-1042.
1988
-
Cell biology of vascular hypertrophy in systemic hypertension..
62:30G-35G.
1988
-
INTERVENTIONAL CARDIAC-CATHETERIZATION AT DUKE-MEDICAL-CENTER.
62:F3-F24.
1988
-
Interventional cardiac catheterization at Duke Medical Center..
62:3F-24F.
1988
-
Contributions of neuroendocrine and local autocrine-paracrine mechanisms to the pathophysiology and pharmacology of congestive heart failure..
62:76E-81E.
1988
-
Comparison of coronary stenosis quantitation results from on-line digital and digitized cine film images..
62:381-386.
1988
-
Reduced thiols and the effect of intravenous nitroglycerin on platelet aggregation..
62:377-380.
1988
-
Clinical behavior of paroxysmal atrial tachycardia..
62:3D-9D.
1988
-
Stability of multilead ST-segment "fingerprints" over time after percutaneous transluminal coronary angioplasty and its usefulness in detecting reocclusion..
61:1232-1237.
1988
-
Perfusion balloon catheter..
61:77G-80G.
1988
-
Correlates of systolic and diastolic blood pressure in men 40 to 59 years of age sampled from United States of America and Union of Soviet Socialist Republics Lipid Research Clinics populations..
61:1071-1075.
1988
-
Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarction..
61:723-728.
1988
-
Evaluation of a QRS scoring system for estimating myocardial infarct size. VI: Identification of screening criteria for non-acute myocardial infarcts..
61:729-733.
1988
-
Helicopter transport of patients during acute myocardial infarction..
61:718-722.
1988
-
Identification of high-risk patients with silent myocardial ischemia after percutaneous transluminal coronary angioplasty by multilead monitoring..
61:29F-35F.
1988
-
Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry)..
61:714-717.
1988
-
Use of initial ST-segment deviation for prediction of final electrocardiographic size of acute myocardial infarcts..
61:749-753.
1988
-
Adoption of thrombolytic therapy in the management of acute myocardial infarction..
61:510-514.
1988
-
Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987..
61:515-518.
1988
-
Clinical significance of exercise-induced bundle branch block..
61:346-348.
1988
-
Randomized trial of prostacyclin infusion in acute myocardial infarction..
61:455-457.
1988
-
Introduction.
61.
1988
-
An explosion of technology.
62:F1-F2.
1988
-
Comparison of high- and low-intensity exercise training early after acute myocardial infarction..
61:26-30.
1988
-
Effect of iron deficiency on tissue oxygen delivery in cyanotic congenital heart disease.
61:605-607.
1988
-
Epicardial ventricular pacemaker electrode longevity in children..
61:104-106.
1988
-
Interventional Cardiac Catheterization at Duke Medical Center - The Duke Interventional Cardiac Catheterization Program.
62.
1988
-
Limitations of balloon angioplasty: Possible causes of restenosis.
62.
1988
-
New international technology: The autoperfusion balloon catheter.
62.
1988
-
Relation of results of exercise stress tests in young women to phases of the menstrual cycle..
61:197-199.
1988
-
Refining the type A hypothesis: emergence of the hostility complex..
60:27J-32J.
1987
-
Autocrine-paracrine mechanisms of vascular myocytes in systemic hypertension..
60:99I-103I.
1987
-
Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease..
60:1101-1105.
1987
-
Calcific valvular aortic stenosis with and without mitral anular calcium..
60:865-870.
1987
-
Outcome in suspected acute myocardial infarction with normal or minimally abnormal admission electrocardiographic findings..
60:766-770.
1987
-
Accuracy of digital angiography for quantitation of normal coronary luminal segments in excised, perfused hearts..
59:1261-1265.
1987
-
Echocardiographic and electrocardiographic characteristics of patients with hypertrophic cardiomyopathy with and without mitral anular calcium..
59:1428-1430.
1987
-
Junctional tachycardia in infants and children after open heart surgery for congenital heart disease..
59:1216-1218.
1987
-
Rethinking sensitivity and specificity..
59:1195-1198.
1987
-
Safety and efficacy of inferior vena caval occlusion to rapidly alter ventricular loading conditions in idiopathic dilated cardiomyopathy..
59:937-942.
1987
-
Prognostic effect of bundle branch block related to coronary artery bypass grafting..
59:798-803.
1987
-
An unusual variant of familial preexcitation..
59:371-373.
1987
-
Implications of local angiotensin production in cardiovascular physiology and pharmacology..
59:59A-65A.
1987
-
A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure..
59:59B-63B.
1987
-
Contribution of afterload, hypertrophy and geometry to left ventricular ejection fraction in aortic valve stenosis, pure aortic regurgitation and idiopathic dilated cardiomyopathy.
59:1398-1404.
1987
-
Exercise ventricular function in mitral valve prolapse.
60:941-942.
1987
-
Identification of the optimal electrocardiographic leads for detecting acute epicardial injury in acute myocardial infarction..
59:20-23.
1987
-
Recovery of systolic and diastolic left ventricular function after a 60-second coronary arterial occlusion during percutaneous transluminal coronary angioplasty for angina pectoris.
60:460-466.
1987
-
Variable responses of mitral valve motion and flow in systemic hypertension and in idiopathic dilated cardiomyopathy.
60:363-367.
1987
-
Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries..
58:1181-1187.
1986
-
Echocardiographic guidance of cardiac catheterization for atrial septal defect in pregnancy..
58:1133-1134.
1986
-
Emergency ventricular pacing from the esophagus in infancy..
58:1105-1106.
1986
-
Medical, psychological and social correlates of work disability among men with coronary artery disease..
58:911-915.
1986
-
Localization of the site of ventricular premature complexes by radionuclide angiographic phase imaging..
58:503-511.
1986
-
Factors affecting use of the Doppler-determined time from flow onset to maximal pulmonary artery velocity for measurement of pulmonary artery pressure in children..
58:352-356.
1986
-
A simplified method to predict occurrence of complete heart block during acute myocardial infarction..
57:1213-1219.
1986
-
Physiologic basis for the age-related decline in aerobic work capacity..
57:1374-1379.
1986
-
Computerized detection of the lactate threshold in coronary artery disease.
57:1088-1091.
1986
-
Noninvasive detection of coronary artery patency using continuous ST-segment monitoring..
57:916-922.
1986
-
Transluminal catheter reperfusion: a new technique to reestablish blood flow after coronary occlusion during percutaneous transluminal coronary angioplasty..
57:684-686.
1986
-
Cardiac function in alcohol-associated systemic hypertension..
57:227-231.
1986
-
Career choices of 135 cardiology trainees at Duke University Medical Center from 1970 to 1984..
57:313-315.
1986
-
Interatrial shunting in atrial septal aneurysm..
57:310-312.
1986
-
Comparison of nifedipine alone with propranolol alone for stable angina pectoris including hemodynamics at rest and during exercise.
57:1022-1028.
1986
-
Left ventricular structure and function by echocardiography in ultraendurance athletes.
58:805-809.
1986
-
Observations on the occurrence of atrial fibrillation in paroxysmal supraventricular tachycardia.
57:571-575.
1986
-
Temporary balloon occlusion of the inferior vena cava for immediate reversal of acute pulmonary edema.
57:886-887.
1986
-
Upright paradoxical posterior wall movement in mitral valve prolapse..
56:804-806.
1985
-
Variant angina and spontaneous coronary artery dissection..
56:485-486.
1985
-
Diagnostic and prognostic significance of minimally elevated creatine kinase-MB in suspected acute myocardial infarction..
55:1478-1484.
1985
-
Diagnostic and prognostic significance of minimally elevated creatine kinase-mb in suspected acute myocardial infarction.
55:1478-1484.
1985
-
Role of receptor mechanisms in the adaptive response to habitual exercise..
55:68D-73D.
1985
-
Analysis of risk factors for sudden death after acute myocardial infarction..
55:621-622.
1985
-
Early exercise training in patients older than age 65 years compared with that in younger patients after acute myocardial infarction or coronary artery bypass grafting..
55:263-266.
1985
-
Prognostic significance of precordial ST-segment depression during inferior acute myocardial infarction..
55:325-329.
1985
-
Value of radionuclide angiography for predicting specific cardiac events after acute myocardial infarction..
55:318-324.
1985
-
Comparison of two-dimensional echocardiographic and angiographic findings in arrhythmogenic right ventricular dysplasia.
55:1506-1508.
1985
-
Evaluation of a QRS scoring system for estimating myocardial infarct size V. Specificity and method of application of the complete system.
55:1485-1490.
1985
-
Evaluation of a QRS scoring system for estimating myocardial infarct size: V. Specificity and method of application of the complete system.
55:1485-1490.
1985
-
Life adaptation after percutaneous transluminal coronary angioplasty and coronary artery bypass grafting.
56:395-398.
1985
-
Calcification of the ascending aorta and aortic and mitral valves in Gaucher's disease..
54:1390-1391.
1984
-
Clinical characteristics of patients younger than 60 years with mitral anular calcium: comparison with age- and sex-matched control subjects..
54:1286-1287.
1984
-
Lipomatous hypertrophy of the atrial septum: diagnosis by combined two-dimensional echocardiography and computerized tomography..
54:1156-1157.
1984
-
Prognostic significance of exercise-induced complex ventricular arrhythmias in coronary artery disease with normal and abnormal left ventricular ejection fraction..
54:1136-1138.
1984
-
Assessment of regional left ventricular function using gated radionuclide angiography..
54:294-300.
1984
-
"Left main equivalent" coronary artery disease: its clinical presentation and prognostic significance with nonsurgical therapy..
53:1489-1495.
1984
-
Effects of beta 1-selective and nonselective beta-adrenoceptor blockade during exercise conditioning in healthy adults..
53:1656-1661.
1984
-
Procainamide cardioversion of fetal supraventricular tachyarrhythmia..
53:1460-1461.
1984
-
Relation between premature ventricular contraction site of origin (defined by radionuclide phase analysis) and subsequent left ventricular function..
53:1028-1033.
1984
-
Effects of age on radionuclide angiographic detection and quantitation of left-to-right shunts..
53:879-883.
1984
-
Complete heart block in Reiter's syndrome..
53:967-968.
1984
-
Hemodynamic correlates for timing intervals, ejection rate and filling rate derived from the radionuclide angiographic volume curve..
53:567-571.
1984
-
Cardiac conduction defects in patients older than 60 years with aortic stenosis with and without mitral anular calcium..
53:169-172.
1984
-
EVALUATION OF A QRS SCORING SYSTEM FOR ESTIMATING MYOCARDIAL INFARCT SIZE .4. CORRELATION WITH QUANTITATIVE ANATOMIC FINDINGS FOR POSTEROLATERAL INFARCTS.
53:706-714.
1984
-
Evaluation of a QRS scoring system for estimating myocardial infarct size. IV. Correlation with quantitative anatomic findings for posterolateral infarcts.
53:700-714.
1984
-
Extreme hypercalcemia and electrocardiographic changes.
54:674-675.
1984
-
Myocardial depression by anesthetic agents (halothane, enflurane and nitrous oxide): quantitation based on end-systolic pressure-dimension relations..
53:243-247.
1984
-
Out-of-hospital management of cardiac arrest by basic emergency medical technicians..
53:68-70.
1984
-
Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery disease..
53:18-22.
1984
-
Relation between radionuclide angiographic regional ejection fraction and left ventricular regional ischemia in awake dogs.
53:294-301.
1984
-
Reply.
53:265.
1984
-
Life-table methods for evaluating antiarrhythmic drug efficacy in patients with paroxysmal atrial tachycardia..
52:1007-1012.
1983
-
Relation between QRS changes and left ventricular function after coronary artery bypass grafting..
52:943-949.
1983
-
Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise..
52:782-788.
1983
-
An improving prognosis over time in medically treated patients with coronary artery disease..
52:444-448.
1983
-
Amrinone therapy for congestive heart failure in outpatients with idiopathic dilated cardiomyopathy..
52:304-308.
1983
-
Natural history of patients with single-vessel disease suitable for percutaneous transluminal coronary angioplasty..
52:225-229.
1983
-
Physical conditioning and left ventricular performance in the elderly: assessment by radionuclide angiocardiography..
52:359-364.
1983
-
Cardiac arrest in young, ostensibly healthy patients: clinical, hemodynamic, and electrophysiologic findings..
52:65-69.
1983
-
Clinical and echocardiographic characteristics of patients with mitral anular calcification. Comparison with age- and sex-matched control subjects..
51:992-995.
1983
-
Cardiac rhabdomyosarcoma presenting as hypereosinophilic syndrome..
51:909-910.
1983
-
Clonidine in congestive heart failure: a vasodilator with negative inotropic effects..
51:791-795.
1983
-
Comparative rates of resolution of QRS changes after operative and nonoperative acute myocardial infarcts..
51:378-381.
1983
-
Evaluation of a QRS scoring system for estimating myocardial infarct size. III. Correlation with quantitative anatomic findings for inferior infarcts..
51:382-389.
1983
-
Comparison of high-dose and medium-dose propranolol in the relief of exercise-induced myocardial ischemia.
52:7-13.
1983
-
Cryosurgery for cardiac arrhythmias: acute and chronic effects on coronary arteries..
51:149-155.
1983
-
Determinants of variable exercise performance among patients with severe left ventricular dysfunction..
51:52-60.
1983
-
Discriminant function analysis using thallium-201 scintiscans and exercise stress variables to predict coronary heart disease.
51:1565-.
1983
-
Effect of atrial fibrillation on atrial blood flow in conscious dogs.
51:1722-1727.
1983
-
Relation of left ventricular mass to geometry of the proximal coronary arteries in the dog.
51:1728-1731.
1983
-
Assessment of the use of the age- and sex-specific United States population as a control group for analysis of survival in coronary artery disease..
50:1279-1282.
1982
-
Prospective evaluation of radionuclide angiocardiography for the diagnosis of coronary artery disease..
50:1212-1216.
1982
-
Anatomic and prognostic implications of an early positive treadmill exercise test..
50:682-688.
1982
-
Onset of atrial fibrillation during antidromic tachycardia: association with sudden cardiac arrest and ventricular fibrillation in a patient with Wolff-Parkinson-White syndrome..
50:353-359.
1982
-
Prognostic implications of ventricular arrhythmias during 24 hour ambulatory monitoring in patients undergoing cardiac catheterization for coronary artery disease..
50:23-31.
1982
-
The spectrum of unstable angina: prognostic role of serum creatine kinase determination..
49:1849-1852.
1982
-
Predictors of the ejection fraction response to exercise in patients with coronary artery disease.
49:1002-1002.
1982
-
Survival in single vessel coronary disease.
49:1008-1008.
1982
-
Exercise responses before and after physical conditioning in patients with severely depressed left ventricular function..
49:296-300.
1982
-
Evaluation of a QRS scoring system for estimating myocardial infarct size. II. Correlation with quantitative anatomic findings for anterior infarcts.
49:1604-1614.
1982
-
THE ELECTROPHYSIOLOGIC BASIS AND MANAGEMENT OF SYMPTOMATIC RECURRENT TACHYCARDIA IN PATIENTS WITH EBSTEINS-ANOMALY OF THE TRICUSPID-VALVE.
49:1223-1234.
1982
-
Digoxin-induced positive exercise tests: their clinical and prognostic significance..
48:655-659.
1981
-
Absent pulmonary valve syndrome in infancy: surgery reconsidered..
48:117-122.
1981
-
Accuracy of radionuclide angiocardiography in the diagnosis of coronary artery disease — A prospective study.
47:444-444.
1981
-
Prognostic significance of left main equivalent stenosis.
47:408-408.
1981
-
Acute effects of ethanol on myocardial blood flow in the nonischemic and ischemic heart..
47:61-67.
1981
-
Cardiac function during rest and exercise in patients with mitral valve prolapse. Role of radionuclear angiocardiography..
47:14-19.
1981
-
Digitalis and exercise testing, a five year followup.
47:416.
1981
-
Early changes in left ventricular size and function after correction of left ventricular volume overload.
47:991-1004.
1981
-
Mitral valve replacement for isolated mitral regurgitation: Analysis of clinical course and late postoperative left ventricular ejection fraction.
48:647-654.
1981
-
The effect of verapamil on the diastolic mechanics of the left ventricle.
47:411.
1981
-
The effects of moderate and high dose propranolol on ventricular function in patients with coronary artery disease.
47:430.
1981
-
UNSTABLE ANGINA-PECTORIS - NATIONAL COOPERATIVE STUDY-GROUP TO COMPARE MEDICAL AND SURGICAL THERAPY .4. RESULTS IN PATIENTS WITH LEFT ANTERIOR DESCENDING CORONARY-ARTERY DISEASE.
48:517-524.
1981
-
Two dimensional echocardiography in mitral, aortic and tricuspid valve prolapse. The clinical problem, cardiac nuclear imaging considerations and a proposed standard for diagnosis..
46:1164-1177.
1980
-
Comparison of multigated radionuclide angiography with ultrasonic sonomicrometry over a wide range of ventricular function in the conscious dog..
46:976-982.
1980
-
Pharmacokinetic-hemodynamic studies of nitroglycerin ointment in congestive heart failure..
46:670-676.
1980
-
Effect of brief and prolonged exercise on left ventricular function..
45:1154-1160.
1980
-
"Harvey," the cardiology patient simulator: pilot studies on teaching effectiveness..
45:791-796.
1980
-
Effects of exercise training on left ventricular function in normal subjects: a longitudinal study by radionuclide angiography..
45:244-252.
1980
-
Evaluation of the left ventricle with two dimensional echocardiography.
46:1117-1124.
1980
-
Nonfatal myocardial infarction in medically treated patients with coronary artery disease.
46:937-942.
1980
-
UNSTABLE ANGINA-PECTORIS - NATIONAL COOPERATIVE STUDY-GROUP TO COMPARE SURGICAL AND MEDICAL THERAPY .3. RESULTS IN PATIENTS WITH S-T SEGMENT ELEVATION DURING PAIN.
45:819-824.
1980
-
Left bundle branch block: angiographic segmental wall motion abnormalities..
44:1046-1049.
1979
-
Effects of antihypertensive therapy on cardiovascular response to exercise.
44:325-328.
1979
-
Effect of oxygen on ischemic myocardial blood flow.
43:391.
1979
-
Influence of experimental myocardial ischemia on beta adrenergic receptors.
43:395.
1979
-
The influence of pH on the electrophysiological effects of lidocaine in guinea pig ventricular myocardium.
43:375.
1979
-
Detection of tricuspid regurgitation with contrast two-dimensional echocardiography.
41:371-371.
1978
-
ALPHA-ADRENERGIC RECEPTORS IN RAT MYOCARDIUM - DIRECT IDENTIFICATION BY BINDING OF [H-3]DIHYDROERGOCRYPTINE.
41:970-970.
1978
-
Reply.
42:1061.
1978
-
Task force I: Standardization of terminology and interpretation.
41:130-145.
1978
-
Unstable angina pectoris: National cooperative study group to compare surgical and medical therapy. II. In-Hospital experience and initial follow-up results in patients with one, two and three vessel disease.
42:839-848.
1978
-
Effects of propranolol on the hemodynamic, coronary sinus blood flow and myocardial metabolic response to atrial pacing..
40:83-89.
1977
-
Cardiac arrest complicating acute myocardial infarction: predictability and prognosis..
39:7-12.
1977
-
Echocardiographic evaluation of tricuspid valve endocarditis: an M mode and two dimensional study..
38:502-507.
1976
-
Nitroglycerin ointment in acute myocardial infarction..
38:474-478.
1976
-
Editorial: Diagnostic considerations in electromechanical dissociation..
38:268-269.
1976
-
Reply—II.
38:136-137.
1976
-
Spectrum of coronary artery disease in idiopathic hypertrophic subaortic stenosis..
38:12-16.
1976
-
Aortocoronary bypass surgery: Correlation of angiographic symptomatic and functional improvement at 1 year..
37:352-357.
1976
-
Aortocoronary bypass surgery: correlation of angiographic symptomatic and functional improvement at 1 yr.
37:352-357.
1976
-
Effect of nitroglycerin ointment on the clinical and hemodynamic response to exercise.
38:162-166.
1976
-
Reply-I.
38:135.
1976
-
Reply-III.
38:137.
1976
-
Significant sex differences in the correlation of electrocardiographic exercise testing and coronary arteriograms..
36:169-173.
1975
-
Ventricular aneurysm with ventricular tachycardia. Report of a case with epicardial mapping and successful resection..
35:696-700.
1975
-
Hereditary progressive atrioventricular conduction defect.
36:297-301.
1975
-
Mahaim and James fibers as a basis for a unique variety of ventricular preexcitation.
36:880-888.
1975
-
Vectorcardiographic diagnosis of anterior myocardial infarction.
35:170-170.
1975
-
Ischemic cardiomyopathy: the myopathy of coronary artery disease. Natural history and results of medical versus surgical treatment..
34:520-525.
1974
-
Reply.
34:746-747.
1974
-
Clinical implications of pulmonary hypertension in mitral stenosis..
32:650-655.
1973
-
Apex cardiogram in patients with prolapsing mitral valve..
32:276-282.
1973
-
Pulmonary wedge catheter..
31:405-407.
1973
-
Effect of different epicardial ventricular pacing sites on left ventricular function in awake dogs.
32:291-294.
1973
-
Quantitative radionuclide angiocardiography for determination of chamber to chamber cardiac transit times..
30:855-864.
1972
-
Spread of excitation from the atrium into thoracic veins in human beings and dogs..
30:844-854.
1972
-
Assessment of ventricular function in coronary artery disease by means of atrial pacing and exercise..
26:107-116.
1970
-
Kerley B lines in total anomalous pulmonaru venous connection below the diaphragm (type 3)..
24:436-440.
1969
-
Immediate hemodynamic effects of acute coronary occlusion and their modification by anesthesia..
22:559-567.
1968
-
Pressure and volume changes of the left ventricle in acute pericardial tamponade..
22:65-74.
1968
-
The ballooning mitral valve in patients with the "precordial honk" or "whoop"..
20:789-795.
1967
-
Mechanisms of action of morphine in the treatment of experimental pulmonary edema..
18:876-883.
1966
-
Determination of leakage currents in medical equipment..
17:437-438.
1966
-
HAZARDS OF ELECTRIC SHOCK IN CARDIOLOGY..
14:537-546.
1964
-
Left axis deviation.
14:330-338.
1964
-
Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).
2017
-
Comparison of hybrid coronary revascularization versus coronary artery bypass grafting in patients ≥65 years with multivessel coronary artery disease
2014
-
Derivation and Validation of a Risk Model for Predicting Clinically-Driven Target Lesion Revascularization in Drug Eluting Stents
2009
-
Retrograde Ascending Aortic Dissection During or After Thoracic Aortic Stent-Graft Placement-Insights from the European Registry on Endovascular Aortic Repair Complications (EuREC)
2009
-
Aortoesophageal Fistula after Thoracic Aortic Stent-Graft Placement: A Rare But Catastrophic Complication of Novel Emerging Technique
2008
-
Gene Expression in Peripheral Blood Reflects the Presence and Extent of Coronary Artery Stenosis
2008
-
Near-infrared Spectroscopic Measurement of Lipid-Core Coronary Plaque Length: Implications for Complete Lesion Coverage in Patients Undergoing Stenting
2008
-
Relationship of the Near Infrared Lipid Core Burden Index in Coronary Segments with Traditional Risk Factors in Patients Undergoing PCI
2008
-
Comparison of outcomes between patients undergoing percutaneous coronary stent implantation with eptifibatide and abciximab: An analysis using propensity score methods
2007
-
Detection of lipid rich plaque by near-infrared spectroscopy (NIRS) in patients undergoing coronary intervention: Results in an unblinded cohort of the SPECTrospic assessment of coronary lipid (SPECTACL) study
2007
-
Impact of thienopyridine administration prior to primary stealing in acute myocardial infarction
2007
-
Incidence and predictors of bleeding among patients undergoing rescue percutaneous coronary intervention after failed fibrinolysis for ST-elevation myocardial infarction
2007
-
Significant reverse remodeling of the left ventricle one year after percutaneous mitral repair with the MitraClip (TM) device
2007
-
Temporal improvements in door-to-balloon times for primary percutaneous coronary intervention_results from the CRUSADE and ACTION registries
2007
-
ASSENT-4 in "French" perspective. Outcomes of STEMI patients treated with pre-hospital thrombolysis in mobile intensive care units in France across trials and registries
2006
-
Local platelet glycoprotein IIb/IIIa receptor occupancy with intracoronary eptitibatide during stenting, the ICE pilot trial
2006
-
Outcomes in elderly patients undergoing PCI treated with bivalirudin monotherapy versus glycoprotein IIb/IIIa inhibitors with hepaiin or LMWH: Results from the randomized ACUITY trial
2006
-
Overlapping paclitaxel elating stents: Early outcomes in the COSTAR II study
2006
-
Anemic patients undergoing percutaneous coronary intervention have a higher mortality even in the absence of major bleeding complications
2005
-
Cardiac MRI predicts functional improvement in patients undergoing percutaneous revascularization of chronically occluded vessels
2005
-
Impact of baseline platelet count on outcomes of patients undergoing primary percutaneous coronary intervention for acute myocardial infarction: Analysis from the CADILLAC trial
2005
-
Adverse impact of multivessel disease on ST-segment recovery and clinical outcome in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
2004
-
Implications of stroke after primary angioplasty in acute myocardial infarction.
2004
-
Outcomes of percutaneous coronary intervention in patients with acute myocardial infarction excluded from randomization: The CADILLAC Trial.
2004
-
Prediction of survival after primary percutaneous coronary intervention by integration of ST-segment recovery and myocardial blush.
2004
-
Prevalence, impact, and predictors of insignificant coronary artery disease in patients with non-ST-segment elevation acute coronary syndromes who undergo angiography: Results from the CRUSADE initiative
2004
-
Reperfusion success and prognosis in patients with anterior compared with nonanterior infarction: Insights from the CADILLAC trial.
2004
-
Activated clotting time values measured with the actalyke machine are consistently lower than measurements obtained with the Hemochron-801
2003
-
Anemia worsens prognosis after primary Angioplasty in acute myocardial infarction: Analysis from the cadillac study
2003
-
Are there any angiographic predictors of abciximab benefit after primary angioplasty for acute myocardial infarction? Analysis from the CADILLAC trial
2003
-
Can stents and glycoprotein IIb/IIIa inhibitors improve the prognosis of young patients with acute myocardial infarction? A report from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) study
2003
-
Does stenting and glycoprotein IIb/IIIa receptor blockade improve ST segment recovery and outcome in patients undergoing primary angioplasty in acute myocardial infarction? The CADILLAC trial
2003
-
Does the use of heparin after primary angioplasty for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa antagonists alleviate recurrent cardiac ischemia? Insights from the CADILLAC study
2003
-
Does treatment with abciximab influence survival in patients with acute myocardial infarction and elevated baseline white blood cell count undergoing primary angioplasty? The CADILLAC trial
2003
-
Impact of age on the outcomes of women with acute myocardial infarction undergoing primary coronary stenting
2003
-
Impact of myocardial blush analysis methodologies in predicting short and long-term mortality after primary angioplasty. The CADILLAC trial
2003
-
Incidence and implications of in-hospital acquired thromhocytopenia in patients undergoing primary angioplasty for acute myocardial infarction
2003
-
Reduction of ischemic injury following coronary intervention: Results of the MC-1 to eliminate necrosis and damage trial (MEND-1)
2003
-
The survival benefit of periprocedural beta-blockers in patients with acute myocardial infarction undergoing primary angioplasty is determined by use of these drugs before admission
2003
-
Treating patients with non-ST-elevation acute coronary syndromes with aggressive antiplatelet agents in the GRACE registry: No observed improvement in hospital outcomes
2003
-
Early results of minimally invasive mitral valve operation using an endoaortic balloon clamp catheter
1997
-
Regional electrophysiologic and rheologic effects of endocardial cryoablation
1982
-
Effects of cardioplegic infusion rate and topical hypothermia on elective cardiac arrest
1982